[***] Confidential Treatment Requested. Confidential portions of this document
have been redacted and have been separately filed with the Commission.
THIS
ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of
October 7, 2004, by and among Xxxxxxxxx Corporation, an Indiana corporation
(“Seller”), Gulf South Medical Supply, Inc., a Delaware corporation
(“Buyer”), Xxxxxxx X. Xxxxxxxxx, the sole shareholder of Seller (the
“Shareholder”), and PSS World Medical, Inc., the sole shareholder of Buyer
(“PSS”).
Preamble
Seller
is in the business of selling and distributing medical supplies to the long-term care
industry (the “Business”). Seller desires to sell and Buyer desires to acquire
certain of the Assets of Seller, and Seller desires to transfer and Buyer desires to
assume certain of the obligations of Seller, all on the terms and subject to the
conditions set forth in this Agreement.
NOW,
THEREFORE, in consideration of the above and the mutual warranties, representations,
covenants and agreements set forth herein, the parties agree as follows:
ARTICLE I
PURCHASE OF RIGHTS AND ASSETS
1.1 |
Agreement
to Purchase and Sell. Subject to the terms and conditions set forth herein, Seller
agrees to sell, convey, transfer, assign and deliver to Buyer, and Buyer agrees to
purchase (the “Acquisition”) all of Seller’s right, title and interest in
and to, the following Assets (collectively, the “Purchased Assets”) of Seller,
free and clear of all Liens: |
|
(a) All accounts receivable of Seller existing on the Closing Date; |
|
(b) The inventory of Seller (the “Purchased Inventory”) existing on the
Closing Date; |
|
(c) All
rights to manufacturer’s or other rebates, credits or discounts in
connection with the Purchased Inventory or Seller’s accounts or trade
payables accrued or payable to Seller on or after the Closing Date; |
|
(d) To
the extent assignable and subject to applicable regulatory approvals, each of
Seller’s valid Permits necessary for Buyer to sell or lease the Purchased
Inventory to customers of the Business; provided that Buyer shall not acquire
or take any Medicare, Medicaid or similar government-issued provider or
supplier agreements, including any numbers assigned pursuant to such
agreements; |
|
(e) The Contracts identified on Schedule 1.1(e) (the “Assumed Contracts”); |
|
(f) The
intangible Assets of Seller relating to the Purchased Assets, including, but
not limited to, all rights under the Assumed Contracts, guarantees from third
parties, licenses, warranties, all right, title and interest to and in the name
“Associated Medical Products” and “Medical Systems
Corporation,” telephone numbers, and trademarks, service marks, logos,
designs, slogans, trade names and other Intellectual Property; |
|
(g) All
operating data and records of the Seller relating to the Business including
customer lists, vendor lists, books, records, manuals, operating guidelines and
practices, sales and promotional data, advertising materials, historical cost
and pricing information, business plans, databases, financial records and
related information of Seller; |
|
(h) All
warranties and documentation relating to the Purchased Inventory and all
guarantees, and any rights of Seller against suppliers and manufacturers; |
|
(i) All
prepaid items including, without limitation, all equipment, lease and other
deposits existing on the Closing Date; |
|
(j) All
Information Technology of Seller (and the Contracts included therein but only
if listed on Schedule 1.1(e)); |
|
(k) All
tangible personal property (and leases or other Contracts relating thereto but
only if listed on Schedule 1.1(e)) used or held for use in the operation
of the Business, including all furniture, machinery, office furnishings,
equipment, vehicles and all office and warehouse supplies existing on the
Closing Date; |
|
(l) The
bank account of Seller identified on Schedule 1.1(l); and |
|
(m) All
other Assets (but as to Contracts, only if listed in Schedule 1.1(e)),
other than the Retained Assets (as defined in Section 1.8), which are (i)
reflected in the books and records of the Business, except to the extent any
such assets have been disposed of in the ordinary course of business or (ii)
used or held for use in the operation of the Business. |
1.2 |
Time and Place of Closing.
The closing (the “Closing”) will take place at 10:00 A.M. on
the date hereof (the “Closing Date”). The place of Closing shall be at the offices of
Xxxxxx &Bird LLP, Atlanta, Georgia. |
1.3 |
Consideration.
The total consideration for the Acquisition shall be: |
|
(a)
the sum of $11,791,827 payable to
Seller, of which $100,000 has been previously paid and $11,691,827 shall be
payable in cash at the Closing in the form of a bank cashier’s or
certified check or a wire transfer; |
|
(b) the
Additional Purchase Price, if any, payable to Seller pursuant to Section 1.4
below; |
|
(c)
the amount, if any, payable to Seller
pursuant to Section 1.5 below; |
|
(d)
the sum of $8,108,173.24 payable to
Fifth Third Bank in full and complete satisfaction of all indebtedness and
obligations of Seller under the Credit Agreement, dated August 3, 2004, by and
between Fifth Third Bank and Seller and any amendment or supplements thereto;
and |
|
(e) Buyer’s
assumption of the Assumed Liabilities ((a) through (e), collectively, the “Purchase
Price”). |
1.4 |
Additional Purchase Price. |
|
(a) For
purposes of this Section 1.4: |
|
(i) “Active
Buying Customer” means a customer that has purchased at least $2,000
per month of supplies from Buyer in at least four of the six calendar
months prior to Closing or in at least two of the three calendar months
prior to Closing. |
|
(ii) “Total
Revenue” shall mean the amount equal to the Gross Revenues of
Existing Customers for the Measurement Period plus the Gross Revenues of
New Customers for the Measurement Period minus [***]. |
|
(iii) “Gross
Revenues of Existing Customers” shall mean the gross revenues
determined in accordance with GAAP attributable to those customers listed
on Schedule 1.4(a), but only if and to the extent that the pricing charged
to such customers in connection with such gross revenues is no less than
[***] of the pricing applicable to such customers during the thirty (30)
days preceding the Closing Date, unless otherwise approved in writing by
an officer of Buyer, and such revenue is generated in compliance with
Section 1.4(g); provided, however,that: |
|
(A) gross revenues from [***] or its consolidated subsidiaries
(collectively, [***]) shall not be included in Gross Revenues of Existing Customers if during the Measurement
Period (i) [***], (ii) Buyer notifies [***] of its election to terminate or not to renew Seller’s existing
customer Contract with [***], or (iii) [***]; |
|
(B) gross
revenues from [***] attributable to the continuation of Buyer’s
historical relationships with [***] shall not be included in Gross
Revenues of Existing Customers under any circumstances, but (unless
[***] is excluded pursuant to Section 1.4(a)(iii)(A)) gross revenues
attributable to any Contract or arrangement with [***] entered into by
Buyer as a renewal or replacement of Seller’s existing customer
Contract with [***], in whole or in part, shall be included in Gross
Revenues of Existing Customers; and |
|
(C) Gross
Revenues of Existing Customers shall exclude any revenue of Seller
deriving from the Oxygen-Related Services on a full assignment basis as
provided for in Section 4.10 and, instead, Seller shall receive a credit
towards the calculation of Gross Revenues of Existing Customers for
Oxygen-Related Services as provided for in Section 4.10. |
-2-
|
(iv) “Gross
Revenues of New Customers” shall mean the gross revenues determined
in accordance with GAAP attributable to any customers obtained by the
Hired Employees (including without limitation [***] and [***]that are not Active Buying Customers but only if and to the
extent that the gross profit margin of such gross revenues meets the
minimum gross profit margin requirements of Buyer currently in effect and
as described on Schedule 1.4(a)(iv), unless otherwise approved in
writing by an officer of Buyer, and such revenue is generated in
compliance with Section 1.4(g); and provided that Gross Revenues of New
Customers shall exclude any revenue of Seller deriving from Oxygen-Related
Services on a full assignment basis as provided for in Section 4.10 and,
instead, Seller shall receive a credit towards the calculation of Gross
Revenues of New Customers for Oxygen-Related Services as provided in
Section 4.10. |
|
(v) “Measurement
Period” shall mean the period beginning October 1, 2004 and ending March
31, 2005. |
|
(b) Within
thirty (30) days after the Measurement Period, Buyer shall calculate and
deliver to Seller a written statement of the Total Revenue and Additional
Purchase Price (the “Revenue Statement”), and shall pay to Seller the
Additional Purchase Price, if any, reflected on the Revenue Statement, in cash
in the form of a bank cashier’s or certified check or by wire transfer.
Subject to Section 1.4(f) below, if the Total Revenue (i) exceeds [***]
(if [***] is included in Gross Revenues of Existing Customers) or exceeds
[***] (if [***] is excluded from Gross Revenues of Existing Customers),
Buyer shall pay Additional Purchase Price in the amount of $4,000,000; (ii) is
between [***] and [***] (if [***] is included in Gross Revenues of Existing Customers)
or between [***] and [***](if [***]is excluded from Gross Revenues of Existing Customers),
Buyer shall pay Additional Purchase Price in the amount of $2,500,000; (iii) is between [***]
and [***] (if [***] is included in Gross Revenues of Existing Customers) or
between [***] and [***] (if [***] is excluded from Gross Revenues of Existing Customers), Buyer
shall pay Additional Purchase Price of $1,500,000; or (iv) is less than [***] (if [***] is included in Gross
Revenues of Existing Customers), or less than [xxx] (if [xxx] is excluded from Gross Revenues of Existing Customers) Buyer shall not pay any Additional Purchase Price. |
|
(c) Buyer
shall use commercially reasonable best efforts to meet historic service levels
of Seller’s Business. In the event such service levels are not met, the
parties shall negotiate in good faith to determine the Total Revenue that would
have been obtained if such service levels had been met; provided, that Buyer
shall not be responsible for the failure to meet any service levels if
performance has been prevented, delayed, restricted or interfered with by acts
of God, such as fires, floods or natural catastrophes, acts of public enemies,
acts of third parties, such as third party manufacturer or distribution delays
or labor strikes, or any other circumstances outside the control of the
Buyer. |
|
(d) Buyer
agrees that until final determination of the Additional Purchase Price, Buyer
shall maintain separate records regarding any customers who generate Gross
Revenues of New Customers or Gross Revenues of Existing Customers (including
credits thereto pursuant to Section 4.10) in such a manner that Total Revenue
can be calculated in accordance with this Section 1.4; provided that for Gross
Revenues of Existing Customers, Buyer need only maintain aggregate customer
records and need not maintain records which try to distinguish revenues
attributable to the Business acquired from Seller from revenues attributable to
Buyer’s pre-existing business. Within thirty (30) days after the end of
each calendar month, Buyer shall provide Seller with interim statements of
Gross Revenues of New Customers and Gross Revenues of Existing Customers
(including credits thereto pursuant to Section 4.10) during such calendar
month, which interim statements shall be for information purposes only, shall
not be binding on either party and shall not be subject to dispute or
recalculation. |
|
(e) Seller
shall have a period of thirty (30) days from receipt of the Revenue Statement
to review and dispute Buyer’s computations. During such thirty (30) day
period, Buyer shall provide Seller and Seller’s representatives access at
reasonable time and at reasonable locations to the books and records of Buyer
related to the Business to the extent reasonably required for Seller to verify
Buyer’s calculations in accordance with this Section 1.4. Upon the earlier
of the date that Seller provides Buyer with written notice of Seller’s
agreement with the Revenue Statement, or, if Seller does not provide Buyer with
written notice of Buyer’s dispute of the determinations reflected in the
Revenue Statement, the last day of such thirty-day period, the Total Revenue
and the Additional Purchase Price shall be deemed to have been finally
determined as set forth in the Revenue Statement. If Seller does deliver to
Buyer written notice of Seller’s dispute within such thirty (30) day
period, Buyer and Seller agree to work together in good faith for not less than
thirty (30) days in an effort to resolve the dispute. If Buyer and Seller are
unable to resolve such dispute, Buyer and Seller agree to submit such matter to
arbitration, in the venue of Xxxxx County, Florida, in accordance with the
then-current commercial rules of the American Arbitration Association. The
Seller shall select one arbitrator, Buyer shall select one arbitrator and the
two arbitrators so chosen shall select a third. Any decision of the arbitration
panel shall require the vote of at least two (2) of such arbitrators and shall
be deemed conclusive and each party shall be deemed to have waived any rights
to appeal therefrom. Any amount payable by a party following the final
resolution of any dispute pursuant to this Section 1.4(e) shall be paid in cash
in the form of a bank cashier’s or certified check or by wire transfer on
or before the tenth (10th) day after such final resolution. |
-3-
|
(f) Buyer
shall have the right to setoff against amounts payable by Buyer to Seller
pursuant to this Section 1.4 up to $600,000 of any shortfall in Working Capital
at Closing as set forth in Section 1.5(e). |
|
(g) Neither
Seller nor Shareholder shall, nor shall Seller or Shareholder indirectly or
directly cause any Hired Employee, Leased Employee or Oxygen Employee to, take
any action in violation of applicable Health Care Laws. Any revenue generated
in violation of the foregoing sentence shall not be counted towards the
calculation of the amount of Additional Purchase Price, if any. Any payments of
Additional Purchase Price made to, or for the benefit of, Seller, which is
subsequently discovered to be based upon revenue generated in violation of the
foregoing sentence, shall be subject to recovery by Buyer. |
1.5 |
Working Capital Adjustment. |
|
(a) The
parties hereto acknowledge and agree that the determination of the Purchase
Price was based in part on the Seller’s delivery of minimum Working
Capital at Closing of $7,447,000. “Working Capital at Closing” means
the current assets of Seller as of the Closing Date (excluding cash) less the
current liabilities of Seller as of the Closing Date (excluding the current
portion of indebtedness for money borrowed and accrued interest thereon, but
including any transaction expenses not paid by Seller prior to Closing)
calculated in accordance with GAAP; provided that in calculating Working
Capital at Closing (i) there shall be no allowance for doubtful accounts
with respect to any trade accounts receivable not listed on Schedule 1.5(a) and
(ii) there shall be a 100% allowance for doubtful accounts with respect to
all of the trade accounts receivable listed on Schedule 1.5(a) except to
the extent (and only to the extent) that any of the trade accounts receivable
listed on Schedule 1.5(a) are actually collected and received by Buyer
within 120 days of the Closing Date. |
|
(b) If
the Working Capital at Closing is equal to or greater than $7,447,000, then
Buyer shall pay to Seller an amount of cash equal to (i) $1,600,000 plus
(ii) the difference obtained by subtracting $7,447,000 from the Working Capital
at Closing. If the Working Capital at Closing is less than $7,447,000 but
greater than or equal to $6,047,000, then Buyer shall pay to Seller an amount
of cash equal to (i) $1,600,000 minus (ii) the difference obtained by
subtracting the Working Capital at Closing from $7,447,000. If the Working
Capital at Closing is less than $6,047,000, then Buyer shall not pay any
additional amount to Seller pursuant to this Section 1.5 and Buyer shall have
the right to setoff against the Additional Purchase Price payable, if any,
pursuant to Section 1.4 of this Agreement an amount equal to the difference
obtained by subtracting the Working Capital at Closing from $6,047,000,
provided that in no event shall the amount of such setoff exceed $600,000. |
|
(c) No
later than 135 days after the Closing Date, Buyer will prepare and deliver to
Seller a statement setting forth the Working Capital at Closing (the “Buyer
Working Capital Statement”) and shall pay to Seller in cash in the form of
a bank cashier’s or certified check or by wire transfer the amount, if
any, determined as provided in Section 1.5(b). Seller and the Shareholder agree
to provide reasonable assistance to Buyer and its representatives and advisors
in connection with the preparation of the Buyer Working Capital Statement. |
|
(d) Seller
shall have a period of thirty (30) days from receipt of the Buyer Working
Capital Statement during which to notify Buyer of any dispute regarding the
calculation of Working Capital at Closing reflected in the Buyer Working
Capital Statement, which notice shall set forth in reasonable detail the basis
for such dispute and Seller’s calculation of the Working Capital at
Closing as it differs from the calculation set forth in the Buyer Working
Capital Statement. During such thirty (30) day period, Buyer shall provide
Seller and Seller’s representatives access at reasonable times and
reasonable locations to the books and records of Buyer related to the Business
to the extent reasonably required for Seller to verify Buyer’s
calculations in accordance with this Section 1.5. Upon the earlier of the date
that Seller provides Buyer with written notice of Seller’s agreement with
the Buyer Working Capital Statement, or, if Seller does not provide Buyer with
written notice of Buyer’s dispute of the determinations reflected in the
Buyer Working Capital Statement, the last day of such thirty (30) day period,
the Working Capital at Closing shall be deemed to have been finally determined
as set forth in the Buyer Working Capital Statement. If Seller does deliver to
Buyer written notice of Seller’s dispute within such thirty (30) day
period, Buyer and Seller agree to work together in good faith for not less than
thirty (30) days in an effort to resolve the dispute. If the Buyer and Seller
are unable to resolve such dispute, Buyer and Seller agree to submit such
matter to arbitration, in the venue of Xxxxx County, Florida, in accordance
with the then-current commercial rules of the American Arbitration Association.
The Seller shall select one arbitrator, Buyer shall select one arbitrator and
the two arbitrators so chosen shall select a third. Any decision of the
arbitration panel shall require the vote of at least two (2) of such
arbitrators and shall be deemed conclusive and each party hereto shall be
deemed to have waived any rights to appeal therefrom. Any amount payable by a
party following the final resolution of any dispute pursuant to this Section
1.5(d) shall be paid in cash in the form of a bank cashier’s or certified
check or by wire transfer on or before the tenth (10th) day after
such final resolution. |
-4-
1.6 |
Assumed
Liabilities. Buyer shall assume on the Closing Date (collectively, the “Assumed
Liabilities”): (i) Sellers’ accounts payable incurred in the ordinary
course of business consistent with past practice and existing as of the Closing Date, but
only to the extent such accounts payable are included in the Working Capital at Closing;
(ii) the performance of obligations arising from and after the Closing Date under
the Assumed Contracts, except to the extent attributable to Seller’s breach
or failure to comply with the terms of any such Contract prior to the Closing Date; and
(iii) all outstanding checks of Seller drawn on the bank account acquired pursuant
to Section 1.1(l) and identified on Schedule 1.6. |
1.7 |
Retained
Liabilities. Except as specifically set forth in Section 1.6 and Section 1.10, Seller
retains all Liabilities (the “Retained Liabilities”), including but not limited
to (i) Liabilities with respect to the Retained Assets or any Contracts not identified on
Schedule 1.1(e), (ii) other than the amounts payable by Buyer pursuant to Section
4.8(d)(i), Schedule 5.1(c) and Section 6.1(h)(iv) or (v), all Liabilities arising
out of or resulting from the Seller’s employment of its employees, including
severance, bonus and any Benefit Plans; (iii) any Liabilities arising out of any act
or omission of Seller and Seller’s operation of the Business; (iv) any Liabilities
arising out of Seller’s submission of claims, compliance with government-imposed
provider or supplier standards, and any other obligations arising under any governmental
provider or supplier agreements entered into by Seller or any predecessor in interest of
Seller, including, without limitation, the Medicare program and state Medicaid programs;
(v) any obligation under an Assumed Contract attributable to Seller’s breach or
failure to comply with the terms of any such Contract prior to the Closing Date; (vi) any
Liabilities for Seller’s Taxes and (vii) all outstanding checks of Seller other than
those identified on Schedule 1.6. |
1.8 |
Retained
Assets. The parties expressly agree that Seller retains all assets that are not
included in the Purchased Assets (the “Retained Assets”), and that, in
particular but without limitation, Buyer is not acquiring or taking (i) any Medicare,
Medicaid or similar government-issued provider or supplier agreements, including any
numbers assigned pursuant to such agreements, (ii) any interest of Seller in AMPMSC, L.P,
(iii) the amount of Seller’s cash on hand as of the Closing Date, if any, that
exceeds the total amount of outstanding checks set forth on Schedule 1.6, or (iv)
those items identified in Schedule 1.8. |
1.9 |
Allocation
of Consideration. The parties hereto intend that the Acquisition be treated as a
taxable transaction for federal and state Tax purposes. Buyer and Seller shall use their
commercially reasonable best efforts to prepare jointly, within ninety (90) days after
the Closing Date, an allocation schedule(the “Allocation Schedule”) of
the consideration paid for the Purchased Assets, together with any assumed liabilities
and capitalizable costs (the “Allocable Consideration”). If there is an
increase or decrease in the Allocable Consideration, then Buyer and Seller shall use
their commercially reasonable best efforts to prepare jointly a revised allocation
schedule (a “Revised Allocation Schedule”) in a manner consistent with the
Allocation Schedule and any prior Revised Allocation Schedule, within ninety (90) days
after the adjustment of the Allocable Consideration occurs. The allocation set forth in
such Allocation Schedule or Revised Allocation Schedule, if there is an adjustment to
Allocable Consideration, shall comply with the rules of Section 1060 of the Internal
Revenue Code. Except to the extent that a contrary position is required by Law, Buyer and
Seller agree to be bound by the allocation set forth in the Allocation Schedule (or the
Revised Allocation Schedule if there has been an adjustment to the Allocable
Consideration) for all purposes of Tax reporting, including the filing of applicable IRS
Forms in accordance with the Allocation Schedule, and the filing of applicable IRS Forms
in the event a Revised Allocation Schedule is prepared. The parties hereto agree that the
Allocation Schedule and the Revised Allocation Schedule, if applicable, shall include an
allocation by state where necessary to calculate applicable state sales or transfer Taxes
applicable to the transaction. |
1.10 |
Prorations.
The following prorations shall be made with respect to the Purchase Assets for (i) personal
property, real estate, occupancy and other similar Taxes, if any, on or with respect to
the Purchased Assets; (ii) the amount of charges for water, telephone, electricity
and other utilities; and (iii) other similar items: (x) amounts related to any time
period prior to the Closing Date for which invoices are received by Buyer prior to the
final determination of Working Capital shall be the liability of Buyer and included as
accounts payable in the Working Capital at Closing; (y) amounts related to any time
period prior to the Closing Date for which invoices are received after the final
determination of Working Capital shall be the liability of Seller; and (z) amounts
related to period on or after the Closing Date shall be the liability of Buyer. After
Closing, Buyer and Seller each shall provide to the other, promptly after receipt, each
third party invoice relating to any such items. By the later of the final determination
of Working Capital at Closing or ten (10) business days after receipt of any such
invoice, Buyer and Seller shall make any payments to the other that are necessary to give
effect to the foregoing proration. Amounts owed hereunder by Seller shall be considered a
Retained Liability of Seller and amounts owed hereunder by Buyer shall be considered an
Assumed Liability of Buyer. |
1.11 |
Assignment
of Contracts. If an attempted assignment of an Assumed Contract pursuant to this
Agreement is ineffective in conveying the benefits thereunder to Buyer or in allowing
Buyer to perform its obligations under the Assumed Liabilities, then Seller and
Shareholder (at no out-of pocket expense to Seller and Shareholder) will cooperate with
Buyer and take such actions as may be reasonably requested by Buyer in order to provide
Buyer all benefits thereunder and to allow Buyer to perform its obligations under the
Assumed Liabilities to the same extent as if such Assumed Contract were assigned to Buyer
at Closing, including taking such actions as may be reasonably requested by Buyer to
enforce for the benefit of Buyer the Seller’s rights thereunder or interests therein
against other parties. |
-5-
ARTICLE II
REPRESENTATIONS AND
WARRANTIES OF SELLER AND SHAREHOLDER
Seller and the Shareholder, jointly
and severally, hereby represent and warrant to Buyer as follows:
2.1 |
Organization,
Standing, and Power. Seller is a corporation duly organized, validly existing, and in
good standing under the Laws of the State of Indiana, and has the power and authority to
carry on its business as it has been and is now being conducted and to own, lease and
operate its Assets. Seller is duly qualified or licensed to transact business as a
foreign entity and is in good standing in all jurisdictions where the character of its
Assets or the nature or conduct of its business requires it to be so qualified or
licensed, except for such jurisdictions in which the failure to be so qualified or
licensed will not have, in the aggregate, a Material Adverse Effect. A copy of the
Articles of Incorporation and all amendments thereto of Seller and the bylaws, as
amended, of Seller and copies of the minutes of Seller, which have been made available to
Buyer for review, are true and complete, in all respects, as in effect on the date of
this Agreement, and accurately reflect all proceedings of the board of directors and
Shareholder of Seller. The Shareholder is the sole Shareholder of Seller, and the record
books of Seller, which have been made available to Buyer for review, contain true and
complete records of the current board of directors and shareholder of Seller and all
prior directors and shareholders of Seller. |
2.2 |
Authorization of Agreement; No Breach. |
|
(a) The
execution, delivery and performance of this Agreement have been duly authorized
by all necessary action of the board of directors and shareholders of Seller.
This Agreement constitutes, and all agreements and other instruments and
documents to be executed and delivered by Seller pursuant to this Agreement
will constitute, legal, valid and binding obligations of Seller enforceable
against Seller in accordance with their respective terms. The execution,
delivery and performance of this Agreement and the agreements and other
documents and instruments to be executed and delivered by Seller pursuant to
this Agreement and the consummation of the transactions contemplated hereby and
thereby will not, subject to obtaining the Consents identified herein, (i)
violate or result in a breach of or Default under the Articles of Incorporation
or bylaws of Seller or any other material instrument or Contract to which
Seller is a party or by which Seller or any of the Purchased Assets is bound;
(ii) violate any Law or Order applicable to or binding upon Seller or upon its
ownership interests, the Purchased Assets or the Business; (iii) except as set
forth on Schedule 2.2 conflict with, constitute a Default under or
require any Consent under any material Contract to which Seller is a party or
by which Seller of any of the Purchased Assets is bound; or (iv) create a Lien
upon the ownership interests, the Purchased Assets or the Business of Seller. |
|
(b) The
Shareholder has the absolute and unrestricted right, power, authority and
capacity to execute and deliver this Agreement and all other instruments and
documents to be executed and delivered by the Shareholder pursuant to this
Agreement and to perform his obligations hereunder and thereunder. This
Agreement and all other instruments and documents to be executed and delivered
by Shareholder pursuant to this Agreement represent the legal, valid and
binding obligations of the Shareholder enforceable against the Shareholder in
accordance with their respective terms. |
2.3 |
No
Subsidiaries. Other than its interest in AMPMSC, L.P., Seller has no Subsidiaries,
and Seller does not own, directly or indirectly, any capital stock or other equity or
ownership or proprietary interest in any corporation, partnership, joint venture or other
Person (whether or not controlled by Seller). |
2.4 |
Financial Statements and Accounting Controls. |
|
(a) Schedule
2.4 contains true and correct copies of the (i) audited balance sheets of
Seller as of December 31, 2003 and 2002, and statements of income and cash
flows for the years ended December 31, 2003, 2002 and 2001 (the “Year-End
Financial Statements”), and (ii) unaudited balance sheet of Seller as of
August 31, 2004 and unaudited statements of income and cash flows for the
eight-month period ended August 31, 2004 (the “Interim Financial Statements”)
(the Year-End Financial Statements and the Interim Financial Statements are
collectively referred to as the “Financial Statements.”) |
|
(b) The
Financial Statements have been prepared in accordance with GAAP except for (i)
the omission of notes to the Interim Financial Statements, and (ii) the fact
that the Interim Financial Statements are subject to normal and customary
year-end adjustments which, individually or in the aggregate, will not be
material. The Financial Statements present fairly the financial position of
Seller as of the dates indicated and present fairly Seller’s results
operations and cash flows for the periods indicated. The Financial Statements
are based on the books and records of Seller, which have been properly
maintained in accordance with reasonable business practices and, in reasonable
detail, accurately and fairly reflect the transactions and dispositions of the
Assets of Seller. |
-6-
|
(c) Seller
maintains such internal accounting controls and procedures as are necessary to
provide reasonable assurance regarding the reliability of Seller’s
financial statements, including controls and procedures that provide reasonable
assurance that (i) the financial records and financial statements are complete
and accurate in all material respects; (ii) transactions are executed and
receipts and expenditures are made only in accordance with management’s
general or specific authorization; (iii) transactions are recorded as necessary
to permit preparation of financial statements of Seller in accordance with GAAP
and to maintain accountability for Seller’s Assets; (iv) access to Seller’s
Assets is permitted only in accordance with management’s general or
specific authorization and any material unauthorized acquisition, use or
disposition of such Assets is prevented or detected in a timely matter; (v) the
recorded accountability of Seller’s Assets is compared with existing
Assets at reasonable intervals and appropriate action is taken with respect to
any differences; (vi) accounts, notes and other receivables are recorded
accurately and proper and adequate procedures are implemented to effect the
collection thereof on a current and timely basis; and (vii) material
information regarding Seller’s operations and financial condition is
accumulated and communicated to Seller’s management, including its
principal executive and financial officers. |
2.5 |
Absence
of Undisclosed Liabilities. Seller has no material Undisclosed Liabilities and there
is no existing condition, situation or set of circumstances which could reasonably be
expected to result in any Undisclosed Liabilities of Seller, except for Liabilities
incurred by Seller since August 31, 2004 in the ordinary course of business consistent
with past practice, none of which are material. |
2.6 |
Absence
of Changes. Except as set forth in Schedule 2.6 or as reflected in the
Interim Financial Statements, since December 31, 2003, Seller’s business has been
operated only in the ordinary course consistent with past practice and there has not been
any transaction or occurrence in which Seller has: |
|
(a) suffered
any Material Adverse Effect or any event, occurrence, development or state of
circumstances which, individually or in the aggregate, could reasonably be
expected to have a Material Adverse Effect; |
|
(b) issued
or delivered any capital stock or other securities or granted any options or
rights to acquire any capital stock or other securities; redeemed or
repurchased, directly or indirectly, any shares of capital stock or other
security or declared, set aside or paid any dividends or made any other
distributions (whether in cash or kind) with respect to any shares of capital
stock or other security; |
|
(c) incurred
any Funded Debt or incurred or become subject to any Liability (other than
Funded Debt) other than in the ordinary course of business consistent with past
practice; |
|
(d) discharged
or satisfied any Lien or paid any Liability other than (i) current liabilities
shown on the balance sheet as of December 31, 2003 included in the Financial
Statements, (ii) current liabilities incurred since that date in the ordinary
course of business consistent with past practice, or (iii) Funded Debt shown on
such balance sheet or incurred since December 31, 2003 in the ordinary course
of business consistent with past practice; |
|
(e) subjected
any of its Assets, tangible or intangible, to any Lien; |
|
(f) sold,
assigned or transferred any of its Assets, or compromised or canceled any
debts, claims or rights, other than in the ordinary course of business
consistent with past practice; |
|
(g) sold,
assigned or transferred any Intellectual Property or other intangible Assets; |
|
(h) suffered
any damage, destruction or loss, whether or not covered by insurance, which
materially and adversely affected the Assets or business of Seller, or suffered
any extraordinary losses or waived any rights of substantial value, in each
case whether or not in the ordinary course of business; |
|
(i) increased
the rate of compensation payable or the level of employee benefits provided by
it to any of its officers, directors, employees or agents over that being paid
or provided to them at December 31, 2003, except general hourly rate increases
and normal merit increases for employees (other than officers) in the ordinary
course of business consistent with past practice; |
|
(j) terminated
or amended any material Contract or other instrument to which it is a party or
by which it or its Assets are bound or suffered any loss or termination, or
threatened loss or termination, of any material business arrangement, including
supplier arrangements; |
|
(k) through
negotiation or otherwise, made any commitment or incurred any Liability,
whether or not enforceable, to any labor organization; |
-7-
|
(l) made
any accrual or arrangement for or payment of any bonus or special compensation
of any kind to any officer, director, employee or agent; |
|
(m) directly
or indirectly paid or entered into a Contract to pay any severance or
termination pay to any officer, director, employee or agent; |
|
(n) changed
any of the accounting principles followed by it or the methods of applying such
principles; |
|
(o) offered
or extended more favorable prices, discounts or other allowances than were
offered or extended regularly on and prior to December 31, 2003; |
|
(p) loaned
funds to or increased the aggregate amount of existing loans to any Person; |
|
(q) entered
into any commitments or transactions, whether or not in the ordinary course of
business, involving aggregate value in excess of $50,000. |
|
(r) written
off as uncollectible any account receivable in excess of $50,000 whether or not
in the ordinary course of business; |
|
(s) hired
or committed to hire any salesperson or other key employee or independent
contractor, or terminated or had resign any salesperson or other key employee
or independent contractor; or |
|
(t) agreed,
whether or not in writing, to take any action described in this Section 2.6. |
|
(a) Schedule
2.7(a) lists all Funded Debt of Seller as of the date hereof, setting forth
the principal amounts outstanding, per annum interest rates and maturity dates
for all such indebtedness. All of the indebtedness (including Funded Debt) of
Seller as of the respective dates of the Financial Statements and as of the
date of this Agreement is accurately reflected in the Financial Statements, and
Seller is not in breach or Default under any of the terms or conditions set
forth in the loan documents governing Seller’s indebtedness (including
Funded Debt) or any other document or instrument related thereto. Except as
disclosed on Schedule 2.7(a), all of the indebtedness of Seller is
prepayable at any time without penalty or premium at the option of Seller.
Except as disclosed on Schedule 2.7(a), (i) the transactions
contemplated in this Agreement will not result in any penalty or incurrence of
any additional obligation or change of any terms with respect to any such
indebtedness, and (ii) Seller has no obligations, Liabilities or indebtedness
to any Affiliate. |
|
(b) Schedule
2.7(b) sets forth a true and complete list of (i) the addresses at which
Seller does conduct or has conducted business, and (ii) the names under which
Seller has conducted business, entered into contracts or held itself out to the
general public. |
|
(a) Seller
has timely filed all federal and state Tax Returns for all periods which were
required to be filed, and such returns are correct and complete in all
respects. Seller has not received notice of any Tax claims being asserted or
any proposed assertion of Tax claims or assessment by any taxing authority, and
no Tax Returns of which applicable statute of limitations are still open have
been subjected to examination or audit by the IRS or any other taxing
authorities. Seller is not under, nor has it received notice of any
contemplated, investigation or audit by the IRS or any other taxing authority
and Seller has not been notified by any taxing authority in a jurisdiction
where Seller does not currently file Tax Returns or pay Taxes that it is
required to file Tax Returns or pay Taxes to such jurisdiction. |
|
(b) Seller
has not executed any extension or waivers of any statute of limitations on the
assessment or collection of any Tax due that is currently in effect. True and
complete copies of all federal and state Tax Returns of Seller for each of the
fiscal years ended December 31, 2001 through December 31, 2003 have been
delivered to Buyer. The statute of limitations with respect to all Federal Tax
Returns and all state Tax Returns filed by or on behalf of Seller for all
taxable years through December 31, 2000, has expired (except for the states of
Michigan, California, Kentucky, Texas and Wisconsin, in which the statute of
limitations for tax returns filed for all taxable years through December 31,
1999, has expired). |
-8-
|
(c) Seller
has paid all Taxes (including penalties and interest in respect thereof, if
any) that were required to be paid whether or not shown on any Tax Return. |
|
(d) The
accruals for Taxes contained in the Financial Statements are adequate to cover
all liabilities for Taxes of the Seller for all periods ending on or before the
date of such Financial Statements and include adequate provision for all
deferred Taxes, and nothing has occurred subsequent to that date to make any of
such accruals inadequate. All Taxes of the Seller have been paid or are
adequately reserved against on the books of the Seller. |
|
(e) Seller
has withheld or collected from each payment made to each of their employees the
amount of all Taxes required to be withheld or collected therefrom and has paid
the same to the proper tax depositories or collecting authorities. The Seller
has timely filed all information returns or reports, including Forms 1099, that
are required to be filed and have accurately reported all information required
to be included on such returns or reports. |
|
(f) Seller
has never made an election under Section 341(f) of the Code and Seller is not
and has never been a United States real property holding corporation as defined
in Section 897 of the Code. |
|
(g) Seller
has been a validly electing S corporation within the meaning of Sections 1361
and 1362 of the Code and under applicable state law at all times since January
1, 2001, and will be an S corporation up to and including the Closing Date. |
|
(h) Seller
is not a party to any Tax sharing, allocation, indemnity or similar agreement
or arrangement (whether or not written). Since January 1, 2001, Seller has not
been a member of any consolidated, combined, affiliated or unitary group of
corporations for any Tax purposes. Seller is not subject to any private letter
ruling of the IRS or comparable rulings of any other taxing authority. |
|
(i) There
are no Liens as a result of any unpaid Taxes upon any of the assets of Seller. |
|
(j) Other
than its interest in AMPMSC, L.P. as general partner, Seller is not a party to
any joint venture, partnership, or other arrangement or contract which could be
treated as a partnership for federal income tax purposes. |
|
(k) Seller
has not constituted either a “distributing corporation” or a “controlled
corporation” (within the meaning of Section 355(a)(1)(A) of the Code) in a
distribution of stock qualifying for tax-free treatment under Section 355 of
the Code (A) in the two (2) years prior to the date of this Agreement or (B) in
a distribution which could otherwise constitute part of a “plan” or
“series of related transactions” (within the meaning of Section
355(e) of the Code) in conjunction with the transactions contemplated by this
Agreement. |
|
(l) There
is no taxable income of Seller that will be required to be reported for a
taxable period beginning after the Closing Date which taxable income was
realized prior to the Closing Date. |
|
(m) Seller
has not participated in any reportable transaction, as defined in Treasury
Regulation Section 1.6011-4(b)(1) or under state law, or a transaction
substantially similar to a reportable transaction. |
2.9 |
Real and Personal Property. |
|
(a) Other
than through its interest in AMPMSC, L.P., Seller does not own any real
property. Schedule 2.9(a) identifies all real property leases of Seller.
Complete and correct copies of such leases have been provided or made available
to Buyer. Each of these leases is in full force and effect on the date hereof.
No Default under any of the terms or conditions set forth in any of such leases
or any other documents or instruments related thereto has occurred or been
asserted by any Person. Seller does not lease any real property as lessor. |
|
(b) Schedule
2.9(b) identifies all leases for material personal property used or
employed by Seller. Complete and correct copies of such leases have been
provided or made available to Buyer. Each of such leases is in full force and
effect on the date hereof. No Default under any of the terms or conditions set
forth in any of such leases or any document or instrument related thereto has
occurred or been asserted by any Person. Seller does not lease any personal
property as lessor. |
-9-
|
(c) Except
as shown on Schedule 2.9(c), Seller has good and marketable title to all
personal property owned by it free and clear of all Liens, and will, upon the
Closing, convey good and marketable title to such personal property free and
clear of all Liens. All material items of personal property and leasehold
improvements owned by Seller are reflected in the unaudited balance sheet of
Seller included in the Interim Financial Statements. All material items of
personal property and leasehold improvements owned or leased by Seller are in
good working condition and repair consistent in all material respects with the
uses to which they are being put, and all such personal property and leasehold
improvements are adequate and usable for the continued operation of the
business of Seller as the same is presently being conducted and are physically
located at one of the places of business of Seller identified on Schedule
2.9(a). The Purchased Assets and the Assumed Contracts comprise
substantially all of the Assets currently used or held for use by Seller to
operate, and are collectively sufficient to provide Buyer with the means and
capability to operate, the Business as and in the manner the Business has been
performed by Seller prior to the date of this Agreement. |
2.10 |
Intellectual Property. |
|
(a) Schedule
2.10 contains a true and complete list of all material Intellectual
Property owned by, registered in the name of, licensed to or used by Seller in
its businesses, or for which application has been made. Except as set forth on
Schedule 2.10, all such Intellectual Property rights are in full force
and effect and constitute legal, valid and binding obligations of the
respective parties thereto; and there have not been and there currently are no
Defaults thereunder by any party. Seller owns, is a valid licensee of or
otherwise has valid rights to use all such Intellectual Property rights free
and clear of all Liens or claims of infringement. Neither Seller nor its
predecessors have infringed in any material respect the Intellectual Property
rights of others and none of the Intellectual Property rights as used in the
business conducted by any such entity infringes upon or otherwise violates the
rights of others in any material respect, nor has any person asserted a claim
of such infringement. Seller is not obligated to pay any royalties to any
person or entity with respect to any such Intellectual Property. |
|
(b) Except
as described on Schedule 2.10, no officer, director or employee of
Seller has entered into any Contract which requires such officer, director or
employee to assign any interest in any Intellectual Property or keep
confidential any trade secrets, proprietary data, customer lists or other
business information or which restricts or prohibits such officer, director or
employee from engaging in activities competitive with Seller. |
2.11 |
Intentionally
omitted. |
2.12 |
Intentionally
omitted. |
2.13 |
Insurance.
A complete and accurate list of all insurance policies held by Seller and now in force
(including, without limitation, property damage, public liability, worker’s
compensation, fidelity bonds, errors and omissions, theft, forgery and other coverage) is
attached hereto as Schedule 2.13, and true and correct copies of all such
insurance policies have been provided or made available to Buyer. All such policies are
in full force and effect, the premiums due thereon have been timely paid and Seller has
otherwise complied with the terms and conditions thereof. Seller is not now in Default
regarding the provisions of any such policy, nor has it failed to give any notice or
present any claim thereunder in due and timely fashion. Except as set forth on Schedule
2.13, there is no claim by Seller pending under any of such policies. Except as set
forth on Schedule 2.13, there is no claim as to which coverage has been
questioned, denied or disputed by the underwriters of such policies or in respect of
which such underwriters have reserved their rights. The consummation of the transactions
contemplated by this Agreement will not constitute a Default under, or otherwise affect
the coverage under, any such insurance policies. |
2.14 |
Compliance with Laws. |
|
(a) Seller
has in effect all Permits necessary for it to own, lease or operate the
Purchased Assets and to carry on its business as now conducted, except for
those Permits the absence of which are not reasonably likely to have,
individually or in the aggregate, a Material Adverse Effect. Seller is in
compliance with all Orders and Permits, and is in compliance in all material
respects with all Laws, applicable to the Business, the Purchased Assets, or
employees conducting its Business. No notice or warning from any Regulatory
Authority with respect to any failure or alleged failure of Seller to comply
with any Law or Permit has been received, nor, to Seller’s knowledge, is
any such notice or warning proposed or threatened. |
|
(b) Except
as set forth on Schedule 2.14, no consent or approval of, prior filing
with or notice to, or other action by, any Regulatory Authority is required in
connection with the execution and delivery of this Agreement or any assignment,
agreement or other instrument to be executed and delivered pursuant to this
Agreement by Seller or the consummation of the transactions provided for herein
or therein except for such consents and approvals that have been obtained and
filings, notices and other actions that have been taken or made. |
-10-
2.15 |
Environmental Matters. |
|
(a) Except
as set forth on Schedule 2.15(a), there is no Litigation related to
Environmental Laws with respect to the ownership, use, condition or operation
of any of the Purchased Assets or the Assets held for use or sale by Seller, or
to the knowledge of Seller and Shareholder, any of its predecessors, in any
court or before or by any Regulatory Authority or private arbitration tribunal
(hereinafter collectively referred to as “Environmental Litigation”).
Except as set forth on Schedule 2.15(a), to the best knowledge of
Seller, there are no existing violations of federal, state or local
Environmental Laws by Seller with respect to the ownership, use, condition,
lease or operation of the Purchased Assets or the Assets held for use or sale
by Seller. Neither Seller, nor to the knowledge of Seller and Shareholder, any
of its predecessors has used any of its Assets or premises for the handling,
treatment, storage, or disposal of any Hazardous Substances except in
compliance will all applicable Environmental Laws. Except as set forth on Schedule
2.15(a), no written or oral notice, or other communication from any court
or Regulatory Authority, of any alleged violation of any Environmental Laws has
been filed or communicated to Seller or, to the knowledge of Seller and the
Shareholder, any of its predecessors with respect to the use, ownership,
condition, operation, or disposal of any of the Purchased Assets or the Assets
held for use or sale by Seller. To the knowledge of Seller and the Shareholder,
no basis exists for the allegation of any such violations. |
|
(b) No
release, discharge, spillage or disposal of any Hazardous Substances in
violation of any Law has occurred or is occurring at any Assets or premises of
Seller or, to the knowledge of Seller and the Shareholder, any of its
predecessors while or before such premises were owned leased, operated, or
managed, directly or indirectly, by any such entity. |
|
(c) To
the best knowledge of Seller, no soil or water in, under or adjacent to any of
the premises of Seller or property formerly held for use or sale by Seller or
any of its predecessors has been contaminated by any Hazardous Substance while
or before such Assets or premises were owned, leased, operated or managed,
directly or indirectly, by Seller or any of its predecessors. |
|
(d) All
waste containing any Hazardous Substances generated, used, handled, stored,
treated or disposed of (directly or indirectly) by Seller or, to the knowledge
of Seller and the Shareholder, any of its predecessors has been released or
disposed of in compliance with all applicable reporting requirements under
applicable Environmental Laws. |
|
(e) Seller
and, to the knowledge of Seller and the Shareholder, its predecessors have
complied with all applicable reporting requirements under applicable
Environmental Laws concerning the disposal or release of Hazardous Substances,
and neither Seller nor, to the knowledge of Seller and the Shareholder, its
predecessors has made a report concerning any of their premises, operations or
activities. |
|
(f) To
the knowledge of Seller and the Shareholder, no building or other improvement
or any premises owned, leased, operated or managed by Seller contains any
friable asbestos-containing materials; and |
|
(g) Copies
of any environmental audits or environmental surveys (in the possession or
known to Seller) of any real estate owned or leased by Seller are attached to Schedule
2.15. |
2.16 |
Litigation
and Claims.There are no outstanding Orders or administrative decisions to
which Seller is subject, and, except as disclosed on Schedule 2.16, there is no
Litigation pending or overtly threatened against or relating to Seller or the Purchased
Assets or its Business, and to the knowledge of Seller and the Shareholder, there is no
specific event which has occurred, or any state of facts or occurrence of any event,
which might give rise to the foregoing. Except as disclosed on Schedule 2.16,
Seller has not been advised by any attorney representing Seller that there are any “loss
contingencies” (as defined in Statement of Financing Accounting Standards No. 5
issued by the Financial Accounting Standards Board in March 1975 (“FASB 5”)),
which would be required by FASB 5 to be disclosed or accrued in the financial statements
of Seller. |
2.17 |
Contracts and Commitments. |
|
(a) Schedule
2.17 sets forth a true, correct and complete list of Contracts to which Seller
is a party or by which the Purchased Assets are bound, and which involve or are
anticipated to involve payment by or the receipt of payment by Seller of any
amounts in excess of $100,000, or that otherwise are described in subsections
(i) through (vii) below, all of which have been made available to Buyer for
review. Except as listed on Schedule 2.17, Seller is not a party to (and
the Purchased Assets are not subject to): |
|
(i) any
Contract for the employment of any Employee; |
|
(ii) any
Contract for the purchase, sale, production or supply, whether on a
continuing basis or otherwise, of goods or services of any type other than
those made in the ordinary course of business consistent with past
practice; |
-11-
|
(iii) any
distributor, sales agency or vendor Contract or sub-contract or any license
agreement, other than those made in the ordinary course of business; |
|
(iv) any
Contract not made in the ordinary course of business, including, but not
limited to any Contract containing restrictive covenants such as covenants
not to compete or other agreement which restricts Seller’s ability to
engage in any business; |
|
(v) any
Contracts that are, in the reasonable opinion of Seller, materially adverse,
onerous, burdensome or otherwise harmful to any of Seller’s Business
or operations or the Purchased Assets; |
|
(vi) any
Contract pursuant to which Seller or any of its Affiliates, employees,
agents, consultants or independent contractors receives a management fee
or a xxxxxxxx and collections fee; or |
|
(vii) any
Contracts, leases, quotas, restrictions or trade conditions upon which the
Business, Purchased Assets, or condition, financial or otherwise, of
Seller substantially depends or that materially affects the Purchased
Assets. |
|
(b) Except
as set forth on Schedule 2.17, (i) each of the Contracts listed on Schedule 2.17 is
in full force and effect on the date hereof, except as the validity of such
Contracts may be affected by actions, events or conditions involving only the
other party thereto, none of which actions, events or conditions have occurred
or exist to the knowledge of Seller and the Shareholder, and (ii) no Default
under any of the terms or conditions set forth in any of the Contracts to which
Seller is a party or any document or instrument related thereto has been
asserted by any party or, to the knowledge of Seller and the Shareholder,
occurred. |
2.18 |
Remuneration Schedule
2.18 contains a complete and accurate schedule of Seller’s employees as of
immediately prior to the Closing Date (the “Employees”), and with respect to
each such Employee, the direct compensation (including wages, salaries and actual or
anticipated bonuses) paid through August 31, 2004. Except as disclosed on Schedule 2.18,
no unpaid salary or wages, other than for the immediately preceding pay period, is now
payable to any of the Employees. |
2.19 |
Union
and Employment Agreements. Except as set forth on Schedule 2.19,
Seller is not a party to any union or union related agreement, nor does Seller have any
written or oral agreement that is not terminable by it at will with any of the Employees
relating to their employment by or performance of services for Seller or their
compensation therefor. To Seller’s knowledge, no union attempts to organize the
employees of Seller have been made nor are any such attempts now threatened. Except as
set forth on Schedule 2.19, Seller has not received notice that any of the
directors, officers or salespersons of Seller will terminate or contemplates terminating
his or her employment or other relationship with Seller currently or at any time within
12 months of the Closing Date. |
2.20 |
Interested Transactions. |
|
(a) Except
as set forth on Schedule 2.20, Seller is not currently a party to any
Contract, loan or other transaction with any of the following persons, or in
which any of the following persons have any direct or indirect interest: |
|
(i) Any
director, officer, employee, shareholder or Affiliate of Seller; |
|
(ii) Any
of the spouses, parents, siblings, children, aunts, uncles, nieces, nephews,
in-laws or grandparents of any of the persons described in clause (i); or |
|
(iii) Any
corporation, trust, partnership or other entity in which any of the persons
described in clauses (i) or (ii) has a beneficial interest (other than in
a corporation whose shares are publicly traded and in which such persons
own beneficially in the aggregate no more than 5% of the outstanding
equity interest). |
|
(b) None
of the directors, officers, shareholders or Affiliates of Seller, nor to the
knowledge of Seller or the Shareholder, any employee of Seller, is an employee,
consultant, service provider, partner, member, principal, officer, director,
shareholder or owner of any business entity which is engaged in a business
which competes with or is similar to the business of Seller. |
-12-
|
(a) Schedule
2.21.(a) sets forth a correct and complete list of every pension,
retirement, profit-sharing, deferred compensation, stock option, employee stock
ownership, severance pay, vacation, bonus or other incentive plan, any other
written or unwritten employee program, arrangement, agreement or understanding,
whether arrived at through collective bargaining or otherwise, any medical,
vision, dental or other health plan, any life insurance plan and all other
employee benefit plans or fringe benefit plans, including, without limitation,
any “employee benefit plan,” as that term is defined in Section 3(3)
of ERISA, currently or expected to be adopted, maintained
by, sponsored in whole or in part by, or contributed to at any time by Target
or any entity that is considered one employer with Target under Section 4001 of
ERISA or Internal Revenue Code Section 414 (“ERISA Affiliate”) for
the benefit of employees, former employees, retirees, directors, independent
contractors, spouses or dependents of any of the foregoing or any other
beneficiaries and under which such employees, retirees, dependents, spouses,
directors, independent contractors, or other beneficiaries are eligible to
participate (collectively, the “Benefit Plans”). Schedule
2.21(a) includes a description of the benefits offered under any unwritten
Benefit Plan. Any Benefit Plan that is an “employee pension benefit
plan,” as that term is defined in Section 3(2) of ERISA, or an
“employee welfare benefit plan” as that term is defined in Section
3(1) of ERISA, is referred to herein as an “ERISA Plan.” Neither
Target nor any ERISA Affiliate has ever sponsored, maintained, contributed to,
or had an “obligation to contribute” (as defined in ERISA Section
4212) to (i) a “defined benefit plan” (as defined in ERISA Section
3(35 and Internal Revenue Code Section 414(j), (ii) a “multiemployer
plan” (as defined in ERISA Sections 4001(a)(3) and 3(37)(A)), (or (iii) a
“multiple employer plan” (meaning a plan sponsored by more than one
employer within the meaning of ERISA Sections 4063 or 4064 or Internal Revenue
Code Section 413(c)). Target has not incurred, nor is reasonably expected to
incur prior to the Closing Date, any liability under Title I or Title IV of
ERISA or under Internal Revenue Code Section 412 other than routine funding
obligations and routine claims for benefits. All Liabilities arising out of or
related to Benefit Plans and ERISA Plans of Target are reflected in the
Financial Statements in accordance with GAAP. Target has made all required
contributions and payments that are due and payable under each Benefit Plan for
all periods through and including the Closing. |
|
(b) True,
correct and complete copies of all written Benefit Plans, as currently in
effect (or listed on Schedule 2.21(a)) have been provided or made
available to Buyer, including (i) all trust agreements or other funding
arrangements, including insurance contracts, and all amendments thereto; (ii)
with respect to any Benefit Plan or amendments, the most recent determination
letter issued by the Internal Revenue Serve as well as any correspondence or
rulings from the Internal Revenue Service, the Department of Labor, or the
Pension Guaranty Corporation within the last six (6) years (other than routine
tax or other required filings); (iii) annual reports or returns, audited or
unaudited Financial Statements, actuarial valuations and reports, and summary
annual reports prepared for any Benefit Plan for the most recent three plan
years; (iv) the most recent summary plan descriptions and any Material
modifications thereto; (v) copies of any filings within the past three (3)
years with the Internal Revenue Service under Revenue Procedure 2003-44 or its
successor or predecessor revenue procedures (EPCRS Program), “Audit-CAP” filings
and “SCP” documents (as such terms are defined in Revenue Procedure
2003-44) and any filings within the past three years with the Department of
Labor under its Voluntary Fiduciary Compliance Program (or predecessor
program); (vi) all personnel, payroll and employment manuals and policies;
(vii) all collective bargaining agreements; (viii) all Contracts with
third-party administrators, actuaries, investment managers, consultants and
other independent contractors that relate to any Benefit Plan; (ix) IRS Forms
5500 filed in each of the most recent three plan years for any Benefit Plan,
including all schedules thereto and opinions of independent accountants; and
(x) complete and accurate written summaries of any Benefit Plan that is oral. |
|
(c) Except
as listed on Schedule 2.21(c), all the Benefit Plans and the related
trusts subject to ERISA comply with and have been administered (i) in all
Material respects in compliance with the provisions of ERISA, (ii) in all
respects with the applicable provisions of the Internal Revenue Code relating
to qualification and tax exemption under Internal Revenue Code Section 401(a)
and 501(a) or otherwise applicable to secure intended tax consequences, (iii)
in all respects with the applicable state or federal securities laws; and (iv)
in all respects with the applicable requirements of any other laws, rules
regulations, ordinances and collective bargaining agreements and no notice has
been received from any government authority questioning or challenging such
compliance. Except as listed on Schedule 2.21(c), all governmental
approvals for the Benefit Plans have been obtained, including, but not limited
to, timely determination letters on the qualification of the ERISA Plans and
tax exemption of related trusts, as applicable under the Internal Revenue Code,
all such governmental approvals continue in full force and effect, and neither
Target nor any administrator or fiduciary of any Benefit Plan is aware of any
circumstances likely to result in the revocation of any government approval.
Neither Target nor any administrator or fiduciary of any such Benefit Plan (or
agent of any of the foregoing) has engaged in any transaction or acted or
failed to act in any manner which could subject any such entity to any direct
or indirect liability (by indemnity or otherwise) for a breach of any
fiduciary, co-fiduciary or other duty under ERISA. No oral or written
representation or communication with respect to any aspect of the Benefit Plans
has been made to employees of Target or any of its predecessors or Subsidiaries
prior to or on the Closing Date that is not in accordance with the written or
otherwise preexisting terms and provisions of such Benefit Plans in effect
immediately prior to the Closing Date. There are no unresolved claims or
disputes under the terms of, or in connection with, the Benefit Plans and no
action, legal or otherwise, has been commenced or threatened with respect to
any claim other than processing of claims in the ordinary course of business. |
-13-
|
(d) With
respect to each applicable Benefit Plan, all annual reports or returns, audited
or unaudited Financial Statements, actuarial valuations, summary annual
reports, summary plan descriptions, and summary of material modifications (i)
are true, correct and complete at the time they were prepared and as of Closing
and (ii) to the extent required by law, have been timely filed with or
delivered to the Internal Revenue Service, Department of Labor, or other
governmental authority and to participants and beneficiaries of the Benefit
Plans. |
|
(e) No “party in interest” (as defined in Section 3(14) of ERISA) or
“disqualified person” (as defined in Section 4975(e)(2) of the
Internal Revenue Code) of any ERISA Plan has engaged in any nonexempt
“prohibited transaction” (within the meaning of Section 4975(c) of
the Internal Revenue Code or Section 406 of ERISA). |
|
(f) Except
as set forth in the Financial Statements, no Liability exists and no event that
could result in a Liability has occurred with respect to any Benefit Plan that
individually or in the aggregate could have a Material Adverse Effect on
Target. |
|
(g) Neither
Target nor its Subsidiaries has ever maintained and does not currently maintain
a Benefit Plan providing welfare benefits (as defined in ERISA Section 3(1)) to
employees after retirement or other separation of service except to the extent
required under Part 6 of Title I of ERISA and Internal Revenue Code Section
4980B(f). |
|
(h) Except
as set forth on Schedule 2.21(h), neither the execution and delivery of
this Agreement nor the consummation of the transactions contemplated by this
Agreement will (i) entitle any person to any benefit (including severance,
unemployment compensation, golden parachute, or otherwise) under any Benefit
Plan or otherwise, (ii) increase any benefits otherwise payable under any
Benefit Plan, (iii) result in any acceleration of the time of payment or
vesting of any such benefit, or (iv) result in any payment or series of
payments by Target, its Subsidiaries, or any ERISA Affiliate to any person of
an “excess parachute payment” (as defined in Code Section 280G) or
any other payment which is not deductible under any Tax law. No “gross up” or
other payment will be required to compensate any person because of the
imposition of any excise Tax. No event has occurred or circumstances exist that
could result in a Material increase in premium costs of any Benefit Plan that
are self-insured, or a Material increase in any benefit costs of any Benefit
Plans that are self-insured. |
|
(i) There
are no restrictions on the rights of Target to amend or terminate any Benefit
Plan without incurring any liability thereunder. No Tax under Code Sections
4980B or 5000 has been incurred with respect to any Benefit Plan and no
circumstances exist which could give rise to such taxes. |
|
(j) Except
as set forth on Schedule 2.21(j), all Benefit Plans that permit
participants to direct the investment plan assets comply with the requirements
of ERISA Section 404(c) and accompanying regulations. |
|
(k) Except
as set forth on Schedule 2.21(k), all individuals participating in (or
eligible to participate in) any Benefit Plan maintained (or contributed to) by
Target are common-law employees. |
|
(l) All
Benefit Plans subject to Section 4980B of the Internal Revenue Code or Part 6
of Title I of ERISA, or both, have been maintained in compliance in all
Material respects with the requirements of such laws and any regulations
(proposed or otherwise) issued thereunder. |
2.22 |
Suppliers
and Customers. Schedule 2.22 sets forth (i) each supplier, vendor, and
manufacturer to whom payments were made which equaled or exceeded $200,000 for the 2003
fiscal year or $100,000 for the current fiscal year to date through August 31, 2004 as
well as each supplier who at any time during the current fiscal year was or now is the
sole source of supply of any good or service (the “Large Suppliers”) and (ii)
the amounts of such payments. Schedule 2.22 sets forth (i) each customer or group
of related customers from whom payments were received which equaled or exceeded $200,000
for the 2003 fiscal year or $100,000 for the current fiscal year to date through August
31, 2004 (the “Large Customers”) and (ii) the amounts of such payments. Except
as set forth in Schedule 2.22, neither any of the Large Suppliers nor any of the
Large Customers has terminated or, to the knowledge of the Seller or the Shareholder,
threatened to terminate its relationship with Seller or has during the last 12 months
decreased or limited or, to the knowledge of the Shareholder, threatened to decrease or
limit its services, supplies or materials to Seller or its usage or purchase of the goods
or services of Seller, as the case may be. Neither Seller nor the Shareholder has any
knowledge that any of the Large Suppliers or any of the Large Customers intends to
terminate or otherwise modify adversely to Seller its relationship with Seller or to
decrease or limit its services, supplies, or materials to Seller or its usage or purchase
of the goods or services of Seller, as the case may be. |
-14-
2.23 |
Certification
for Reimbursement; Reimbursement from Third-Party Payors. |
|
(a) Seller
has existing participation agreements and/or provider and supplier agreements
(including provider numbers)(the “Certifications”) with (i) the
Medicare program, the state Medicaid programs (within the states in which
Seller conducts business) and other federal and state (within the states in
which Seller conducts business) health care programs and (ii) such private
non-governmental programs, including without limitation any private insurance
program, under which Seller directly or indirectly is presently receiving
payments (collectively (i) and (ii), the “Payors”). Seller possesses all
Certifications necessary to enable it to carry on its operations as presently
conducted and for Seller to receive reimbursement from the Payors. Seller has
never been excluded, sanctioned, disciplined or suffered any adverse action
with respect to any of the Certifications or with respect to its participation
in the Payors’ programs, nor has there been any decision not to renew any
provider or third-party Payor agreement. There are no pending or, to the
knowledge of Seller, threatened, actions, investigations or circumstances, nor,
to the knowledge of Seller, is there a basis for any action, investigation or
circumstance which would adversely affect the Certifications, or the
participation or renewal of participation in any Payors’ program. True,
complete and correct copies of all surveys of Seller or its predecessors in
interest and conducted in connection with any Payor’s program or licensing
or accrediting body during the past two (2) years have been provided to Buyer. |
|
(b) To
the best of Seller’s knowledge, Seller has timely filed all reports and
xxxxxxxx required to be filed by it prior to the date hereof with respect to
the Payors’ programs and other insurance carriers and all such reports and
xxxxxxxx are complete and accurate in all material respects and have been
prepared in compliance with all applicable laws, regulations and principles
governing reimbursement and payment claims. True and correct copies of such
reports and xxxxxxxx for the most recent year have been made available to
Buyer. Seller has paid or caused to be paid all known and undisputed refunds,
overpayments, discounts or adjustments which have become due pursuant to such
reports and xxxxxxxx and has no Liability under any Payors’ program for
any refund, overpayment, discount or adjustment. Except as set forth and
described in Schedule 2.23, Seller has not, through the Closing Date,
received any notice of audit, recoupment, or claim review from any of the
Payors with respect to any action or inaction or business conducted by Seller. |
2.24 |
Inspections
and Investigations. Except as set forth and described in Schedule 2.24, (i) no
right of Seller, nor, to the knowledge of Seller, the right of any licensed professional
or other individual directly or contractually affiliated with Seller, to receive
reimbursements pursuant to any Payor’s program has been terminated or otherwise
adversely affected as a result of any investigation or action, whether by any Regulatory
Authority or other third party, (ii) neither Seller, nor, to the knowledge of
Seller, any licensed professional or other individual directly or contractually
affiliated with Seller or who has provided services to Seller during the past three (3)
years, has been the subject of any inspection, investigation, survey, audit, monitoring
or other form of review by any Regulatory Xxxxxxxxx, xxxxx association, professional
review organization, accrediting organization or certifying agency based upon any alleged
improper activity on the part of such individual, nor has Seller received any notice of
deficiency during the past three years in connection with the operations of Seller’s
business, (iii) to the best knowledge of Seller, there are not presently, and at the
Closing Date there will not be, any outstanding deficiencies or work orders of any
Regulatory Authority having jurisdiction over Seller, or its Business or Assets, or
requiring conformity to any applicable agreement, Law or bylaw, including but not limited
to, the Payor programs, and (iv) to the best knowledge of Seller, there is not any
notice of any claim, requirement or demand of any licensing or certifying agency or other
third party supervising or having authority over Seller, or its Business or Assets, to
rework or redesign any part thereof or to provide additional furniture, fixtures,
equipment, appliances or inventory so as to conform to or comply with any existing Law or
standard. Attached as part of Schedule 2.24 are copies of all reports,
correspondence, notices and other documents relating to any matter described or
referenced therein. |
2.25 |
Certain
Relationships. Except as set forth on Schedule 2.25, Seller has not: |
|
(i)
offered, paid, solicited or received anything of value, paid directly or
indirectly, overtly or covertly, in cash or in kind (“Remuneration”)
to or from any physician, family member of a physician, or an entity in
which a physician or physician family member has an ownership or
investment interest, including, but not limited to: |
|
(A)
payments for personal or management services pursuant to a medical director
agreement, consulting agreement, management contract, personal services
agreement, or otherwise; |
|
(B)
payments for the use of premises leased to or from a physician, a family member
of a physician or an entity in which a physician or family member has an
ownership or investment interest; |
|
(C)
payments for the acquisition or lease
of equipment, goods or supplies from a physician, a family member of a
physician or an entity in which a physician or family member has an ownership
or investment interest; or |
-15-
|
(ii) offered, paid, solicited or received any Remuneration (excluding fair
market value payments for services, equipment or supplies) to or from any
healthcare provider, pharmacy, drug or equipment supplier, distributor or
manufacturer, including, but not limited to: |
|
(A) payments
or exchanges of anything of value under a warranty provided by a manufacturer
or supplier of an item to Seller; or |
|
(B) discounts,
rebates, or other reductions in price on a good or service received by Seller; |
|
(iii)
offered, paid, solicited or received any Remuneration to or from any
person or entity in order to induce business, including, but not limited
to, payments intended not only to induce referrals of patients, but also
to induce the purchasing, leasing, ordering or arrangement for any good,
facility, service or item; |
|
(iv)
entered into any joint venture, partnership, co-ownership or other
arrangement involving any ownership or investment interest by any
physician, or family member of a physician, or an entity in which a
physician or physician family member has an ownership or investment
interest, directly or indirectly, through equity, debt, or other means,
including, but not limited to, an interest in an entity providing goods or
services to Seller; |
|
(v)
entered into any joint venture, partnership, co-ownership or other
arrangement involving any ownership or investment interest by any person
or entity including, but not limited to, a hospital, pharmacy, drug or
equipment supplier, distributor or manufacturer, that is or was in a
position to make or influence referrals, furnish items or services to, or
otherwise generate business for Seller; or |
|
(vi)
entered into any agreement providing for the referral of any patient for
the provision of goods or services by Seller, or payments by Seller as a
result of any referrals of patients to Seller. |
2.26 |
Xxxxx;
Fraud and Abuse; False Claims; HIPAA. Neither Seller nor, to the best of Seller’s
knowledge, persons and entities providing professional services to Seller, have engaged
in any activities which are prohibited under 42 U.S.C. § 1320a-7b, 42 U.S.C.
§ 1395nn or 31 U.S.C. § 3729-3733 (or other federal or state statutes
related to false or fraudulent claims) or the regulations promulgated thereunder pursuant
to such statutes, or related state or local statutes or regulations, or which are
prohibited by rules of professional conduct, including but not limited to the following:
(a) knowingly and willfully making or causing to be made a false statement or
representation of a fact in any application for any benefit or payment; (b) knowingly and
willfully making or causing to be made any false statement or representation of a fact
for use in determining rights to any benefit or payment; (c) failing to disclose
knowledge by a claimant of the occurrence of any event affecting the initial or continued
right to any benefit or payment on its own behalf or on behalf of another, with intent to
fraudulently secure such benefit or payment; and (d) knowingly and willfully soliciting
or receiving any remuneration (including any kickback, bribe or rebate), directly or
indirectly, overtly or covertly, in cash or in kind or offering to pay or receive such
remuneration (i) in return for referring an individual to a person for the furnishing or
arranging for the furnishing of any item or service for which payment may be made in
whole or in part by Medicare or Medicaid, or (ii) in return for purchasing, leasing, or
ordering or arranging for or recommending purchasing, leasing, or ordering any good,
facility, service or item for which payment may be made in whole or in part by Medicare
or Medicaid. Seller has not engaged in activities that are prohibited under The Health
Insurance Portability and Accountability Act of 1996, 42 U.S.C. § 1320 d through
d-8, as amended (“HIPAA”), and Seller is in compliance with the privacy and
transaction standards regulations issued under HIPAA and applicable state privacy Laws
and regulations. |
2.27 |
Absence
of Certain Business Practices. Except as set out on Schedule 2.27, neither
Seller, nor any officer or director of Seller, nor to the best of Seller’s
knowledge, any employee or agent of Seller or any other person or entity acting on behalf
of Seller, acting alone or together, has (i) received, directly or indirectly, any
rebates, payments, commissions, promotional allowances or any other economic benefits,
regardless of their nature or type, from any customer, governmental employee or other
person or entity with whom Seller has done business directly or indirectly, or (ii) directly
or indirectly, given or agreed to give any gift or similar benefit to any customer,
governmental employee or other person or entity who is or may be in a position to help or
hinder Seller (or assist Seller in connection with any actual or proposed transaction)
which, in the case of either clause (i) or clause (ii) above, would reasonably be
expected to subject Seller to any damage or penalty in any civil, criminal or
governmental litigation or proceeding. Neither Seller, nor, to the knowledge of Seller,
any officer thereof has used any funds for unlawful contributions, gifts, entertainment
or other expenses relating to political activity or otherwise, or has made any direct or
indirect unlawful payment to governmental officials or employees from the entities’ funds
or been reimbursed from the entities’ funds for any such payment, or is aware that
any other person associated with or acting on behalf of Seller has engaged in any such
activities. |
-16-
2.28 |
Guarantees,
Warranties and Discounts. Except as set forth on Schedule 2.28, (a)
Seller has not given any guarantee, warranty or discount with respect to any of the
products sold or services provided by it, and (b) Seller is not required to provide any
letters of credit, bonds, or other financial security arrangements in connection with its
suppliers or customers. |
2.29 |
Brokers
and Finders. Buyer shall not have any Liability for any broker’s fee, finder’s
fee, consultant’s fee or similar third party remuneration by reason of any action of
Seller or Shareholder. |
2.30 |
Schedules.
All Schedules attached hereto are true, correct and complete as of the date of this
Agreement. Matters disclosed on each Schedule shall be deemed disclosed only for purposes
of the matters to be disclosed on such Schedule and shall not be deemed to be disclosed
for any other purpose unless expressly provided therein or unless the disclosure is
clearly on its face responsive to another representation or warranty set forth in this
Article II. |
ARTICLE III
REPRESENTATIONS AND
WARRANTIES OF BUYER AND PSS
Buyer and PSS, jointly and severally,
hereby represent and warrant to Seller as follows:
3.1 |
Organization,
Standing, and Power. Buyer is a corporation duly organized, validly existing, and in
good standing under the Laws of the State of Delaware, and has the power and authority to
carry on its business as it has been and is now being conducted and to own, lease and
operate the Purchased Assets. PSS is a corporation duly organized, validly existing and
in good standing under the Laws of the State of Florida, and has the power and authority
to carry on its business as it has been and is now being conducted. |
3.2 |
Authorization of Agreement; No Breach. |
|
(a) The
execution, delivery and performance of this Agreement has been duly authorized
by all necessary corporate action of Buyer. This Agreement constitutes, and all
agreements and other instruments and documents to be executed and delivered by
Buyer pursuant to this Agreement will constitute, legal, valid and binding
obligations of Buyer enforceable against Buyer in accordance with their
respective terms. The execution, delivery and performance of this Agreement and
the agreements and other documents and instruments to be executed and delivered
by Buyer pursuant to this Agreement and the consummation of the transactions
contemplated hereby and thereby will not, subject to obtaining the consents
identified herein, (i) violate or result in a breach of or Default under the
articles or certificate of incorporation or bylaws of Buyer or any other
material instrument or agreement to which Buyer is a party or is bound; or (ii)
violate any Law or Order applicable to or binding upon Buyer or upon its
ownership interests, Assets or business. |
|
(b) The
execution, delivery and performance of this Agreement has been duly authorized
by all necessary corporate action of PSS. This Agreement constitutes the legal,
valid and binding obligation of PSS, enforceable against PSS in accordance with
its terms. The execution, delivery and performance of this Agreement and the
consummation of the transactions contemplated hereby will not, subject to
obtaining the consents identified herein, (i) violate or result in a breach of
or Default under the articles or certificate of incorporation or bylaws of PSS
or any other material instrument or agreement to which PSS is a party or is
bound; or (ii) violate any Law or Order applicable to or binding upon PSS. |
3.3 |
Brokers and Finders. Neither Seller nor Buyer shall have any Liability for any broker’s
fee, finder’s fee, consultant’s fee or similar third party remuneration by
reason of any action of Buyer or PSS. |
ARTICLE IV
ADDITIONAL AGREEMENTS
4.1 |
Press
Releases. Seller and Buyer shall consult with each other as to the form and substance
of any press release or other public disclosure materially related to this Agreement or
any other transaction contemplated hereby; provided, that nothing in this Section 4.1
shall be deemed to prohibit or restrict any party hereto from making any disclosure which
its counsel deems necessary or advisable in order to satisfy such party’s disclosure
obligations imposed by Law. |
4.2 |
Retained
Liabilities. Seller agrees to pay or otherwise satisfy all Retained Liabilities as
and when due, subject to its right to contest such Retained Liabilities in good faith. |
4.3 |
Assumed
Liabilities. Buyer agrees to pay or otherwise satisfy all Assumed Liabilities as and
when due, subject to its right to contest such Assumed Liabilities in good faith. |
-17-
4.4 |
Taxes.
Seller shall pay any and all transfer, recording, documentary, stamp, sales, use or
similar Taxes arising in connection with the consummation of the Acquisition. |
4.5 |
Termination
of Assumed Names. Within five (5) business days following the Closing Date, Seller
shall have filed with the Secretary of State of the State of Indiana to terminate its
assumed business names “Associated Medical Products” and “Medical Systems
Corporation.” |
4.6 |
Access
to Records. At all times following the Closing, Seller and the Shareholder will allow
the officers and authorized representatives of Buyer access upon reasonable notice to
such of Seller’s books and records that are retained by Seller as part of the
Retained Assets as such parties may from time to time reasonably request in connection
with a bona fide business purpose. At all times following the Closing, Buyer will allow
Seller, Shareholder and its and his representatives and advisors access upon reasonable
notice to such of the books and records related to the Business that are purchased by
Buyer as part of the Purchased Assets as such parties may from time to time reasonably
request in connection with a bona fide business purpose. In addition, Buyer shall (a)
preserve and maintain such books and records (in paper or electronic form) that are part
of the Purchased Assets consistent with Buyer’s document retention policies and (b)
provide to Seller and Shareholder such back-office administrative personnel support as
Seller and Shareholder may reasonably request (at no out-of-pocket cost to Seller or
Shareholder) for the retrieval and delivery to Seller of such books and records for any
bona fide business purpose, such as Seller’s need to respond to Tax audits of
Seller. |
4.7 |
Covenant Not To Compete. |
|
(a) Each
of Seller and Shareholder covenants and agrees that, for a period of five (5)
years from the date hereof, it and he, respectively, will not, directly or
indirectly, engage in any activity prohibited pursuant to the terms of this
Section 4.7. |
|
(b) Each
of Seller and Shareholder agrees that for the term of this Section 4.7, neither
it or he, respectively, without Buyer’s prior written consent, will
directly or indirectly, (i) own, manage, operate, control or participate in, or
be associated with as a director, officer, shareholder, partner, joint
venturer, employee, consultant or otherwise, any medical equipment or supply
distribution business which competes, or which can reasonably be expected to
compete, directly or indirectly, with Buyer within the continental United
States (the “Prohibited Business”), which is the distribution
territory of Seller as of the date of this Agreement; (ii) become financially
interested in any Person engaged in any such Prohibited Business, or (iii)
solicit or attempt to solicit any employee or independent contractor of Buyer
to work in a Prohibited Business either for Seller or Shareholder personally or
on behalf of any other Person. Notwithstanding the foregoing, Shareholder shall
not be in violation of this Section 4.7(b) solely by investing in less than
five percent (5%) of the securities of any publicly traded company. |
|
(c) Each
of Seller and Shareholder agrees that for the term of this Section 4.7, neither
it or he, respectively, will in any way, directly or indirectly, for itself,
himself or on behalf of or in conjunction with any other Person: |
|
(i) solicit
or divert away or attempt to solicit or divert away any customer that was
served by Seller prior to the date hereof; |
|
(ii) solicit
or divert away or attempt to solicit or divert away any prospective
customer of Seller to which a written proposal was submitted during the
twelve (12) month period prior to the date hereof; or |
|
(iii) solicit
or divert away or attempt to solicit or divert away any prospective
customer of Seller to which a specific oral proposal was submitted during
the twelve (12) month period prior to the date hereof. |
|
(d) Seller
and Shareholder acknowledge that they have and may in the future come into
possession of certain confidential and proprietary information relating to the
business, operations, condition and prospects of Buyer (including the business
of Seller on and prior to the date hereof) or its affiliates, and agrees that
all such confidential and proprietary information is the sole and exclusive
property of Buyer. Seller and Shareholder shall not disclose any such
confidential or proprietary information, directly or indirectly, nor use it in
any way, either during the term of this Agreement or at any time thereafter,
except as required by law or by any court or governmental agency or body. All
files, records, documents, information, data and similar items in any medium
whatsoever relating to the business, assets or prospects of Buyer (including
the Business of Seller on and prior to the date hereof) or its affiliates shall
remain the exclusive property of Buyer and shall not be copied or removed from
the premises of Buyer, under any circumstances whatsoever without the prior
written consent of Buyer. Confidential information shall not include that
information that is generally available to the public at the time of such
disclosure or that Seller or Shareholder obtains from a third party not in
violation of any obligation of confidentiality on the part of such third party
to Buyer. |
-18-
|
(e) Seller
and Shareholder acknowledge that any violation of this Section 4.7 will cause
irreparable harm to Buyer and that damages are not an adequate remedy. Seller
and Shareholder therefore agree that Buyer shall be entitled to injunctive
relief enjoining, prohibiting and restraining Seller and/or Shareholder from
the continuance of any such violation, in addition to any monetary damages
which might occur by reason of a violation of this Section 4.7 or any other
remedies at law or in equity, including, without limitation, specific
performance. |
|
(f) The
covenants set forth in this Section 4.7 are and shall be deemed and construed
as separate and independent covenants. Should any part or provision of such
covenants be held invalid, void or unenforceable by any court of competent
jurisdiction, such invalidity or unenforceability shall not render invalid,
void or unenforceable any other part or provision thereof. Specifically, and
without limiting the generality of the foregoing, if any portion of this
Agreement is found to be invalid by a court of competent jurisdiction because
its duration, the territory and/or the restricted activities are invalid or
unreasonable in scope, such duration, territory and/or restricted activity, as
the case may be, shall be redefined by consideration of the reasonable concerns
and needs of Buyer’s business interests such that the intent of Buyer, in
consummating the transactions contemplated by the Agreement, will not be
impaired and shall be enforceable to the fullest extent permissible under
applicable Law. |
|
(g) Seller
and Shareholder agree and acknowledge that the covenants contained herein are
provided in connection with the sale of a business by Seller to Buyer. Seller
and Shareholder acknowledge that this Section 4.7 is a material inducement to
Buyer to enter into this Agreement, and that such acquisition is of direct and
material benefit to Seller and Shareholder and is good and adequate
consideration for the covenants given herein. Seller and Shareholder also
acknowledge that Buyer has a present and future expectation of business within
the territory set forth in 4.7(b) above. Seller and Shareholder acknowledge the
reasonableness of the term, geographic area and scope of the covenants set
forth in this Agreement, and agree that neither of them will, in any action,
suit or other proceeding, deny the reasonableness of, or assert the
unreasonableness of, the premises, consideration or scope of the covenants set
forth herein. Shareholder further acknowledges that complying with the
provisions contained in this Agreement will not preclude him from engaging in a
lawful profession, trade or business, or from becoming gainfully employed in
such a way as to provide a standard of living for himself, the members of his
family, and those dependent upon him or the sort and fashion to which he and
they have become accustomed and may expect. Seller and Shareholder acknowledge
and agree that the amounts to be paid by Buyer hereunder are in consideration
for a five-year agreement. |
|
(h) The
rights and obligations of each of Seller and Shareholder under this Section 4.7
are personal and are not assignable, and no attempted assignment thereof or any
portion thereof by Seller or Shareholder shall release either from any
obligations hereunder. This Section 4.7 shall inure to the benefit of Buyer and
its successors and assigns. |
|
(a) Hired Employees. Buyer Exhibit 4 sets forth a list of all Employees who
are designated to receive an offer from Buyer on the Closing Date (each a “Closing
Date Offered Employee”). Seller shall terminate the employment of each
Closing Date Offered Employee, effective as of the Closing Date, whether or not
such individual accepts Buyer’s offer of employment, and any Closing Date
Offered Employee who accepts Buyer’s offer of employment (each a “Closing
Date Hired Employee”) shall become an employee
of Buyer on the day following the Closing Date. Any Employee who is not a
Closing Date Offered Employee and who is not an Oxygen Employee shall be
hereinafter referred to as a “Leased Employee,” and shall be so
designated on Schedule 4.8(a)(ii). Buyer shall have no obligation at any
time to offer employment to, or to hire, any Leased Employees or Oxygen
Employees; however, Buyer may interview, offer employment to, and, upon five
(5) business days written notice to Seller, hire any such Leased Employees and
Oxygen Employees in its sole discretion upon terms and conditions acceptable to
Buyer, either during the Lease Term (as hereinafter defined) or thereafter; provided,
however, that Buyer may not hire any Oxygen Employee prior to the end of
the Interim Period described in Section 4.10. Seller shall terminate the
employment of any Leased Employee or Oxygen Employee who receives such an offer
from Buyer during the Lease Term, and such termination shall be effective as of
the day immediately prior to the effective date of Buyer’s offer of
employment. A Leased Employee or Oxygen Employee who accepts Buyer’s offer
of employment (each an “Additional Hired Employee,” and all such
individuals collectively with the Closing Date Hired Employees, the “Hired
Employees”) shall become an employee of Buyer on the date specified in
Buyer’s offer effective the day after such date of termination (a Hired
Employee’s effective date of employment with Buyer hereinafter the “Effective
Hire Date”). Seller shall not make competing offers or proposals, or
directly or indirectly seek to induce any Employees not to accept an offer of
employment made by Buyer, or otherwise interfere with Buyer’s rights under
the foregoing provisions of this Section 4.8(a). |
-19-
|
(b) Employee
Leasing; Independent Contractor. |
|
(i) Leased
Employees shall remain employees of Seller and act solely in that capacity
pursuant to this Section 4.8. Seller shall make available to Buyer the Leased
Employees to provide such services during the Lease Term (as hereinafter
defined) as Buyer, in its sole discretion, determines must be performed with
respect to the Purchased Assets and Buyer’s business (“Services”)
during the transition period of the Lease Term until Buyer’s own employees
are capable of performing such Services. |
|
(ii) Seller
shall be an independent contractor for all purposes in leasing such Leased
Employees and providing Services to Buyer pursuant to this Section 4.8 and
shall not be considered or permitted to be an agent, servant, joint venturer or
partner of Buyer. Similarly, at no time shall Buyer be a co-employer or joint
employer of the Leased Employees, and all persons furnished, used, retained, or
hired by or on behalf of Seller shall at all times be considered to be solely
the employees of Seller. |
|
(iii) Buyer
shall have the right to provide day-to-day technical direction of the Leased
Employees solely in connection with the Leased Employees’ provision of the
Services. Notwithstanding the foregoing, it is the intent of the parties that
(i) Leased Employees continue to be employed solely by Seller, continue to
administratively report to Seller for purposes of payroll, employee benefits
(except as otherwise expressly set forth in Section 4.8(g)) and other
administrative matters, and continue to be subject to Seller’s employment
policies and procedures; and (ii) Buyer shall have no authority to terminate,
discipline, counsel, review, evaluate, pay, provide employee benefits (except
as specifically set forth in Section 4.8(g)) to or otherwise affect the
employment relationship between the Leased Employees and Seller, and shall not
in any case be considered to be an employer of such Leased Employees or to
assume responsibilities or obligations of an employer. Seller shall ensure that
the Services are performed in a manner consistent with the manner in which such
Services were performed prior to the Closing Date, and at a level consistent
with that prevailing in Buyer’s industry for such Services. |
|
(iv) Upon
receipt of a verbal or written complaint from Buyer specifying that a Leased
Employee has worked or reported for work under the influence of alcohol or
unauthorized drugs or controlled substances or has violated any Law or policy
of Buyer, Seller shall take prompt corrective action and, if requested to do so
by Buyer, shall remove the person as a Leased Employee. |
|
(c) Term
of Leasing Agreement. Seller shall commence providing Leased Employees to
Buyer on the Closing Date, and shall continue to provide such Leased Employees
until the earlier of: (i) The effective date specified in a written notice from
Buyer to Seller stating that Buyer no longer requires Leased Employees to be
provided; or (ii) Six (6) months after the Closing Date (the “Lease Term”). |
|
(d) Compensation
and Benefits; Seller Obligations. |
|
(i) Upon
request and delivery of evidence of payment by Seller, Buyer shall reimburse
Seller amounts that have been paid by Seller for severance in accordance with
Schedule 4.8(d) to Employees who are terminated by Seller but do not
become Hired Employees, in an aggregate amount up to but not to exceed
$340,459.82 plus an amount equal to the employer-portion of the actual FICA tax
imposed on such severance. To the extent that the total amount paid or payable
by Seller for severance in accordance with Schedule 4.8(d) or otherwise
exceeds $340,459.82 plus the FICA amounts as set forth in the preceding
sentence, such payments shall be the sole responsibility of Seller and shall
not be reimbursed by Buyer. Other than the foregoing payment, Seller shall be
solely responsible for any Liabilities (A) relating to compensation (including
severance) earned by Employees (including Employees who become Hired Employees)
through the Closing Date or with respect to Leased Employees, through the
expiration of the Lease Term, and (B) relating to the Benefit Plans. |
|
(ii) Following
the Closing Date, Seller shall be solely responsible for paying compensation
and providing employee benefits (except as otherwise expressly set forth in
Section 4.8(g)) to each Leased Employee until immediately prior to the Leased
Employee’s Effective Hire Date or until the Leased Employee’s
employment with Seller is terminated. Such compensation shall be paid by Seller
at the rate specified in Schedule 2.18, and such employee benefits shall
be provided in accordance with the terms of the Benefit Plans in effect as of
the Closing Date. Seller and Buyer agree that Buyer is not adopting, continuing
or assuming any Liability relating to compensation paid to any Leased Employees
at any time with respect to their employment with Seller, or relating to the
Benefit Plans, and that Buyer’s sole obligation under this Section 4.8 is
to pay Seller the Leasing Fee (as hereinafter defined) subject to the terms and
conditions of this Section 4.8. |
-20-
|
(iii) Seller
shall take all actions necessary, including adoption of any necessary
amendments or modifications prior to the Closing Date, to ensure that none of
the Hired Employees are entitled to receive severance benefits under any
Benefit Plan that provides such benefits. |
|
(iv) Within
five (5) days after the Closing Date, Seller shall issue notices pursuant to
the Worker Adjustment Retraining Notification Act (“WARN”) to all of
the Leased Employees. Except for Liabilities that arise as a result of Seller’s
failure to provide effective WARN notices to Leased Employees as required
herein, to the extent that any Liabilities or payments under the WARN Act or
any similar provision of Law arise as a consequence of the transactions
contemplated by this Agreement, Buyer shall be responsible for any of those
Liabilities or payments. Seller shall not terminate the employment of any of
the Leased Employees within sixty (60) days of the date on which WARN Notice is
given, except for cause and with advance notice to Buyer; provided, however,
that Buyer shall not terminate the Lease Term prior to the expiration of such
sixty (60) day period. |
|
(i) Throughout
the term described in Section 4.8(c), Seller shall maintain a policy or
policies of insurance for each type of coverage and with the minimum limits
stated below: |
|
(1) Comprehensive
General Liability Insurance: Seller shall provide comprehensive general
liability insurance, including broad form contractual coverage, insuring
against liability arising out of or based upon any act or omission of Seller,
its respective officers, directors, or employees. Such insurance shall provide
coverage to a limit of not less than that in effect as of the Closing Date, and
shall specifically name Buyer as an “additional insured.” |
|
(2) Umbrella
Policy: Seller shall maintain an umbrella insurance policy with a coverage
limit of not less than that in effect as of the Closing Date. |
|
(3) Workers’ Compensation
Insurance. Seller shall maintain workers’ compensation insurance
coverage for each of Seller’s employees consistent with the coverage in
effect for Employees immediately prior to the Closing Date. |
|
(ii) Seller
shall present proof of such insurance coverage to Buyer prior to the
commencement of the term of this Section 4.8 for Buyer and at any time
thereafter upon Buyer’s request. Seller agrees to authorize Buyer to
obtain information relating to Seller’s insurance coverage directly from
Seller’s insurers. |
|
(f) Seller’s
401(k) Plan. Without limiting the generality of this Section 4.8, Seller
and Buyer expressly agree that Buyer will not adopt, maintain or assume in any
way the 401(k) Plan of Seller. Seller shall take all necessary and appropriate
steps to terminate such 401(k) Plan effective on Closing Date and to fully vest
the account balances of all participants in such Plan. Buyer shall have no
Liability whatsoever to Employees or former employees of Seller with respect to
retirement benefits for service with Seller, whether or not such employees are
offered employment by, or become employees of, Buyer. Seller will make employer
matching contributions to the accounts of all Employees under the 401(k) Plan
of Seller for that portion of the plan year in which the Closing Date occurs
during which such Employees were eligible to receive an employer matching
contribution without regard to any requirement that the Employee be employed on
any particular date or earn any minimum number of hours of service to receive
such contribution; ; provided, however, that Seller shall not make any
contributions (whether employer matching contributions or employee deferrals)
to the Seller’s 401(k) Plan relating to Employee compensation that is
earned with respect to the period following the Closing Date. As soon as
practicable following the Closing Date, Seller shall cause the account balances
of all participants under the 401(k) Plan of Seller to be distributed in
accordance with applicable Law. |
|
(g) Health
Plan Obligations. On the Closing Date, Buyer shall assume ownership of and
responsibility for payment of the premiums with regard to that health benefit
insurance policy issued by United Healthcare and listed as an Assumed Contract
under Schedule 1.1(e) (the “Health Policy”). Notwithstanding
the foregoing, and with respect to the period up to and including the Closing
Date, Seller shall retain sole responsibility for any and all Liabilities
(including but not limited to payment of premiums for the Health Policy), and
shall not allow the Health Policy to lapse or otherwise terminate for any
reason without the express written agreement of Buyer. In addition, up to and
including the Closing Date, Seller shall retain responsibility for compliance
with the group health benefit continuation requirements of Sections 601 through
609 of ERISA and Sections 162(k) and 4980B of the Code with respect to all
“group health plans” as that term is defined by ERISA, whether or not
such group health plan represents an Assumed Contract. Seller shall also be
responsible for and shall ensure its group health plans comply with the notice
and coverage certification requirements of Section 701 of ERISA and Section
9801 of the Code. |
-21-
|
(h) Seller
Compliance with Law. As it relates to the Employees and their employment
with Seller, including any services of Leased Employees provided pursuant to
this Section 4.8, Seller shall comply with all applicable Laws, including the
Code, ERISA, FICA, the Occupational Safety and Health Act, Fair Labor Standards
Act, and any other Laws relating to employees, employment, employee benefits,
employment taxes (including withholding and reporting obligations) and
mandatory insurance under workers’ compensation or disability insurance. |
|
(i) Payment
and Billing for Services Rendered by Seller. |
|
(i) Buyer
shall pay a fee to Seller equal to the aggregate amount of compensation paid by
Seller to the Leased Employees, and for Seller’s aggregate out-of-pocket
costs for providing employee benefits under the Benefit Plans to Leased
Employees (including, without limitation, expenses incurred by Seller pursuant
to Sections 4.8(d)(ii) and 4.8(e), but excluding amounts for severance in
excess of $340,459.82 and related FICA amounts as provided in Section
4.8(d)(i)), in each case solely with respect to the period of the Lease Term
and a period up to but not to exceed thirty (30) days thereafter if and to the
extent reasonably necessary for the ordinary wind-up of Seller (the
“Leasing Fee”). The Leasing Fee shall include the (i) employer
contribution of Seller to the Benefit Plans on behalf of the Leased Employees,
including the employer portion of premium costs for providing insured welfare
benefits, (ii) fees and expenses paid to any third party administrators and
service providers for their services provided to the Benefit Plans during the
Lease Term; and (iii) compensation paid to and reasonable costs incurred by
Seller for up to but not to exceed thirty (30) days after the Lease Term if and
to the extent reasonably necessary for the ordinary wind-up of Seller and only
with respect to a type and amount of Leased Employees reasonably required for
the ordinary wind-up of Seller. Notwithstanding the foregoing, including the
provisions of Section 4.8(g), Buyer shall not be required to pay the Leasing
Fee or any portion thereof attributable to costs, fees, expenses, taxes,
damages, penalties or other obligations (A) that relate to Liability for
compensation or for Benefit Plans related to the period prior to the Closing
Date, whether or not such Liability has been disclosed by Seller to Buyer
pursuant to this Agreement, (B) that arise because of Seller’s
noncompliance with the terms of any Benefit Plan or applicable Law, or (C) that
arise because of Seller’s breach of its covenants under this Agreement. |
|
(ii) From
time to time at reasonable intervals, as Seller incurs a Leasing Fee, Seller
shall deliver an invoice to Buyer with respect to the amount of the Leasing Fee
due for such interval and detailing such Leasing Fee. Buyer shall pay the
invoice, except for any amounts reasonably disputed by Buyer, promptly after
Buyer’s receipt thereof. |
|
(iii) In
the event that Buyer reasonably disputes any amount on the invoice, Buyer shall
notify Seller in writing within ten (10) days immediately following Buyer’s
receipt of the invoice setting forth the reasons Buyer is disputing the
invoice. The dispute shall thereafter be resolved in the same manner as
Disputed Losses are resolved pursuant to Section 6.6 of this Agreement. |
|
(iv) Seller
shall maintain complete and accurate payroll, accounting and other records, in
accordance with generally accepted accounting practices and applicable Law, to
substantiate Seller’s charges for the Leasing Fee and Seller’s
compliance with the terms of this Agreement. Seller shall retain such records
for a period of at least two years from the date of final payment of the
Leasing Fee. For purposes of ensuring compliance with this Agreement and for
other reasonable purposes in connection with the transactions contemplated by
this Agreement, Buyer will have the right, upon reasonable notice and during
normal business hours, to inspect, examine and take extracts from, or make
copies of, such books and records maintained by Seller. |
4.9 |
Bulk
Sales. The parties hereby waive compliance with any state Bulk Transfer Act or
similar state bulk sales law, to the extent applicable to the transactions contemplated
by this Agreement. Seller shall indemnify Buyer, as a Retained Liability, with respect to
any Liabilities based upon, arising out of or resulting from such waiver (except that
such indemnity obligation shall not extend to any Liabilities that are expressly included
in the Assumed Liabilities). |
4.10 |
Interim
Arrangement for Oxygen-Related Services. During that period of time between the
Closing Date and the date on which Ancillary Management Solutions, Inc. becomes a
certified medical supply and equipment vendor for the Wisconsin Medicaid program (the
“Interim Period”), Seller agrees to provide or arrange the sale or rental, as
appropriate, of Oxygen-Related Services to any full assignment customers (either existing
or new). Buyer shall use commercially reasonable efforts to have Ancillary Management
Solutions, Inc. certified as a medical supply and equipment vendor by the Wisconsin
Medicaid program in a timely manner. Seller shall rent from Buyer the equipment and
purchase from Buyer the supplies necessary to perform its obligations under this Section.
Buyer shall charge Seller for such equipment and supplies an amount equal to the amount
reimbursed by Wisconsin Medicaid for such Oxygen-Related Services net any costs actually
incurred by Seller in providing such Oxygen-Related Services. Revenue generated from
Oxygen-Related Services for Seller’s full assignment customers shall be the sole
property of Seller and shall not be counted towards the Additional Purchase Price
provided for in Section 1.4. Seller shall receive a credit towards the Gross Revenues of
Existing Customers or |
-22-
|
the Gross
Revenues of New Customers, as appropriate, for (i) any such equipment rented and supplies
purchased from Buyer pursuant to this Section during the Measurement Period and (ii) any
costs actually incurred by Seller in providing such Oxygen-Related Services during the
Measurement Period. Buyer and Seller agree that during the Interim Period Seller shall be
solely responsible for the provision of Oxygen-Related Services, including without
limitation, (i) the provision of Oxygen-Related Services in compliance with Health Care
Laws; and (ii) continued employment or contractual relationship with any staff necessary
for the provision of Oxygen-Related Services, including without limitation, respiratory
therapists (“Oxygen Employees”); provided,however, that Buyer,
and not Seller, shall be solely responsible and liable for any act or omission of Buyer
and its employees, agents, officers and directors. In the event that Seller requires the
use of any assets or the services of any Hired Employees or Leased Employees to fulfill
its obligations hereunder, Seller shall enter into a separate agreement with Buyer to use
such assets, Hired Employees or Leased Employees with the associated cost being
ultimately passed through to Buyer. During the Interim Period, Buyer shall make available
to Seller the same computer systems, procedures, information gathering systems and
delivery services as are currently in place and used by Seller for the provision of
Oxygen-Related Services. At the end of the Interim Period, any Oxygen Employees shall be
treated in the same manner as employees generally in Section 4.8. |
ARTICLE V
CLOSING DELIVERIES
5.1 |
Closing
Deliveries of Seller and Shareholder. At the Closing, Seller and Shareholder shall
deliver to Buyer: |
|
(a) a
Xxxx of Sale reasonably satisfactory in form to Buyer and duly executed by
Seller, assigning and transferring to Buyer all of Seller’s right, title
and interest in and to the Purchased Assets; |
|
(b) an
Assignment and Assumption Agreement reasonably satisfactory in form to Buyer
and duly executed by Seller under which Buyer assumes the Assumed Liabilities; |
|
(c) executed
employment and noncompetition agreements in the form of Exhibit 5.1(c) from
the Hired Employees set forth on Schedule 5.1(c); |
|
(d) payoff
and estoppel letters and releases evidencing discharge, removal and termination
of the Liens identified on Schedule 5.1(d), in form and substance
reasonably satisfactory to Buyer, which shall be effective at or prior to the
Closing subject solely to payment by Buyer of the payoff amounts set forth
therein; |
|
(e) certified
copies of resolutions duly adopted by Seller’s Board of Directors and
shareholders, as necessary, evidencing the taking of all corporate action
necessary to authorize the execution, delivery and performance of this
Agreement, and the consummation of the transactions contemplated hereby; |
|
(f) a
duly executed Third Amendment to that certain Commercial Lease dated September
1, 1992, between AMPMSC, L.P. an Indiana limited partnership, as Landlord, and
Seller, as Tenant, as amended by First Amendment to Commercial lease dated
March 25, 1998; as amended by Second Amendment to Commercial Lease dated June
15, 2003, for the property located at 0000 Xxxxxx Xxxxx, Xxxxxxxxxxxx, Xxxxxxx;
and |
|
(g) an
executed Employment Agreement and Restrictive Covenant in the form of Exhibit 5.1(g) from
Xxxx Xxxxxxxx. |
5.2 |
Closing
Deliveries of Buyer. At the Closing, Buyer shall deliver to Seller and/or Shareholder: |
|
(a) an
Assignment and Assumption Agreement reasonably satisfactory in form to Seller,
under which Buyer assumes the Assumed Liabilities; |
|
(b) immediately
available funds in the amount of $11,543,501 to an account designated by
Shareholder and immediately available funds in the amount of $148,326 to
Account Number 765-0000000 at Fifth Third Bank; |
|
(c) immediately
available funds in the amount of $8,108,173.24 to Fifth Third Bank in
satisfaction of the payoff letter identified in Section 5.1(e); |
|
(d) immediately
available funds (i) to Xxxx Xxxxxxxx in the amount set forth in his Employment
Agreement and Restrictive Covenant and (ii) to those Hired Employees set forth
on Schedule 5.1(c) in the respective amounts set forth opposite to their
names on Schedule 5.1(c). |
-23-
ARTICLE VI
INDEMNIFICATION
6.1 |
Definitions.
As used in this Agreement, the following terms shall have the following meanings: |
|
(a) “Buyer
Indemnified Party” shall mean the Buyer and its Affiliates. |
|
(b) “Buyer
Losses” shall mean any and all Losses incurred by a Buyer Indemnified
Party as a result of, based upon or arising out of (i) any Retained
Liability, (ii) a breach of any of the representations or warranties of Seller
or Shareholder set forth in this Agreement or in any document or agreement made
or executed by Seller or Shareholder pursuant to this Agreement, (iii) a
breach of any of the covenants and agreements of Seller or Shareholder (except
to the extent such covenants and agreements are waived by Buyer pursuant to the
terms of this Agreement) set forth in this Agreement or in any document or
agreement made or executed by Seller or Shareholder pursuant to this Agreement
and (iv) other than the Assumed Liabilities, the operation of Seller’s
businesses and the employment of Seller’s employees prior to the Closing
Date. |
|
(c) “Indemnifiable
Loss” shall mean any Loss for which an Indemnitee is entitled to be
indemnified under this Article VI. |
|
(d) “Indemnitee” shall
mean a Person entitled (or a Person asserting it is entitled) to
indemnification under this Article VI. |
|
(e) “Indemnitor” shall
mean a party obligated (or a Person that an Indemnitee asserts is obligated) to
indemnify, defend and hold harmless another party under this Article VI. |
|
(f) “Loss” shall
mean any direct or indirect demand, claim, payment or failure to receive
payment, obligation, action or cause of action, assessment, loss, liability,
damage, diminution in value, cost or expense, including without limitation,
penalties, interest on any amount payable to a third party as a result of the
foregoing, and any legal or other expense reasonably incurred in connection
with investigating or defending any claim or action, whether or not resulting
in any liability. |
|
(g) “Seller
Indemnified Party” shall mean the Seller and its Affiliates. |
|
(h) “Seller
Losses” shall mean any Loss incurred by a Seller Indemnified Party as
a result of, based upon or arising out of (i) a breach of any of the
representations or warranties of Buyer set forth in this Agreement or in any
document or agreement made or executed by Buyer pursuant to this Agreement, (ii) a
breach of any of the covenants and agreements of Buyer (except to the extent
such covenants and agreements are waived by Seller pursuant to the terms of
this Agreement) set forth in this Agreement or in any document or agreement
made or executed by Buyer pursuant to this Agreement, including any payment
obligation of Buyer set forth in Article I of this Agreement, (iii) any Assumed
Liability, (iv) any claim by any Leased Employee arising out of relating to any
act or omission by Buyer or any employee or agent of Buyer (unless such act or
omission on which such claim was based was expressly authorized by Seller) in
connection with Buyer’s solicitation, hire, or failure to hire any Leased
Employee or other activities alleged to have violated any Laws governing the
hiring, interviewing, or selection of employees or potential employees; and (v)
any claim by any Leased Employee arising out of or relating to any act or
omission (unless such act or omission was expressly authorized by Seller) in
connection with a Leased Employee’s relationship with Buyer after the
Closing Date, including, without limitation, with respect to any: (a) alleged
discriminatory treatment of such Leased Employee on the basis of race, age,
national origin, sex, religion, pregnancy, military status, sexual orientation
or actual or perceived disability; or (b) alleged work-related injury, illness
or death incurred after the Closing Date arising from or in connection with the
tortuous conduct of Buyer or any employee, agent or subcontractor of Buyer. |
6.2 |
Indemnity
by Seller and Shareholder. Seller and Shareholder, jointly and severally, agree, to
the fullest extent permitted by Law, to indemnify, defend, and hold harmless any and all
Buyer Indemnified Parties from and against any and all Buyer Losses. |
6.3 |
Indemnity
by Buyer and PSS. Buyer and PSS jointly and severally agree, to the fullest extent
permitted by Law, to indemnify, defend, and hold harmless any and all Seller Indemnified
Parties from and against any and all Seller Losses. |
|
(a) An
indemnification claim based upon Sections 6.1(b)(ii) or 6.1(h)(i) (other than
due to a breach of a representation or warranty contained in Sections 2.2, 2.8,
2.9(c) (first sentence), 2.23, 2.24, 2.25, 2.26, 2.27 and 3.2 of this
Agreement) shall be subject to the following limitations: |
-24-
|
(i) Such claims must be initiated by delivery of a Loss Notice within two (2)
years following the Closing Date. |
|
(ii) The
Buyer Indemnified Parties may recover (A) only to the extent Buyer Losses in
the aggregate have exceeded $100,000 (the “Threshold Amount”)
(in each case, without regard to any qualifications or limitations
regarding materiality or Material Adverse Effect contained in the
applicable representation or warranty) and (B) only up to an aggregate
amount of (x) $5,000,000 plus (y) amounts paid to Seller pursuant to
Sections 1.4 and 1.5 of this Agreement (the “Maximum Amount”).
After the aggregate of all such Buyer Losses suffered or incurred by the
Buyer Indemnified Parties exceeds the Threshold Amount (in each case,
without regard to any qualifications or limitations regarding materiality
or Material Adverse Effect contained in the applicable representation or
warranty), Seller and the Shareholder shall be obligated to indemnify the
Buyer Indemnified Parties for all such Buyer Losses that are in excess of
the Threshold Amount; provided that the Threshold Amount shall not be
counted as a claim applying against the Maximum Amount. |
|
(iii) The
Seller Indemnified Parties may recover (A) only to the extent Seller Losses
in the aggregate have exceeded the Threshold Amount and (B) only up to the
Maximum Amount. After the aggregate of all such Seller Losses suffered or
incurred by the Seller Indemnified Parties exceeds the Threshold Amount,
Buyer shall be obligated to indemnify the Seller Indemnified Parties for
all such Seller Losses that are in excess of the Threshold Amount;
provided that the Threshold Amount shall not be counted as a claim
applying against the Maximum Amount. |
|
(b) For
an indemnification claim based upon Section 6.1(b)(i) or (iv) or Section
6.1(h)(iii), (iv) or (v), the Buyer Indemnified Parties and the Seller
Indemnified Parties, respectively, may recover only up to an amount which,
together with any amounts recovered by such parties for the claims addressed in
Section 6.4(a), do not exceed the Maximum Amount. |
6.5 |
Notice
of Claim. If the Indemnitee incurs an Indemnifiable Loss, or, subject to Section 6.7,
should the Indemnitee negotiate a proposed settlement in satisfaction of a potential
Indemnifiable Loss, it shall promptly provide written notice to Indemnitor stating in
reasonable detail the nature and amount of such Indemnifiable Loss or potential
Indemnifiable Loss (a “Loss Notice”). If Indemnitor disputes the amount sought
under any such Loss Notice or otherwise disputes the right of the Indemnitee to be
indemnified hereunder, it shall provide the Indemnitee a written notice objecting to such
claim for indemnification within twenty (20) days of the date any such Loss Notice is
received by the Indemnitor (a “Protest Notice”). If no Protest Notice is
received by the Indemnitee within twenty (20) days from the date on which any Loss Notice
is received by the Indemnitor, then such failure to timely object pursuant to a Protest
Notice shall constitute a final and binding acceptance by the Indemnitee of its
obligation to indemnify, defend and hold harmless the Indemnitee from the Losses
described in the Loss Notice under this Article VI. |
6.6 |
Procedure
With Respect to Disputed Indemnifiable Loss. If Indemnitor and the Indemnitee are
unable to resolve a Loss Notice with respect to which the Indemnitee has received a
Protest Notice (a “Disputed Loss”) within thirty days of the date the
Indemnitee receives the Protest Notice, then such Disputed Loss shall be submitted to
arbitration in the venue of Xxxxxx County, Indiana, if the Indemnitee is a Seller
Indemnified Party, or Xxxxx County, Florida, if the Indemnitee is a Buyer Indemnified
Party, in accordance with the then-current commercial arbitration rules of the American
Arbitration Association. If a Disputed Loss is to be arbitrated, the Indemnitor and the
Indemnitee shall select one arbitrator in accordance with the then-current commercial
arbitration rules of the American Arbitration Association. Any decision of the arbitrator
shall be deemed conclusive and each party shall be deemed to have waived any rights to
appeal therefrom. The parties shall attempt in good faith to reach a resolution of a
Disputed Loss, whether by agreement of the parties or by arbitration, within sixty (60)
days of the date of the Protest Notice in regard to which the dispute relates. Each party
shall bear their own legal fees and related expenses incurred in connection with the
arbitration proceedings. |
6.7 |
Survival.
All representations and warranties contained in this Agreement or in any certificate
delivered pursuant to this Agreement shall survive the Closing for a period of two (2)
years notwithstanding any investigation conducted with respect thereto or any knowledge
acquired as to the accuracy or inaccuracy of any such representation or warranty;
provided, however, that the representations and warranties contained in Sections 2.2,
2.8, 2.9(c) (first sentence), 2.15, 2.23, 2.24, 2.25, 2.26, 2.27 and 3.2 shall survive
the Closing and shall remain in full force and effect until the expiration of all
statutes of limitations related thereto. No investigation by or provision of information
to any Buyer Indemnified Party shall relieve Seller or Shareholder of any liability under
this Agreement. |
6.8 |
Access.
With respect to any third party claims with respect to which an Indemnifiable Loss has
been asserted, each party hereto, as may reasonably be related to any such claim, shall
provide access to the Representatives of the other parties during normal business hours
to all Assets, personnel, books, records (including Tax records), Contracts and all of
the business records of such party and will furnish to such other parties copies of all
such documents as may be reasonably requested at the requesting party’s expense. |
-25-
ARTICLE VII
MISCELLANEOUS
|
(a) Except
as otherwise provided herein, the capitalized terms set forth below shall have
the following meanings: |
|
“Affiliate”of
a Person shall mean: (i) any other Person directly, or indirectly through one or
more intermediaries, controlling, controlled by or under common control with such Person;
(ii) any officer, director, partner, employer, or direct or indirect beneficial
owner of any 10% or greater equity or voting interest of such Person; or (iii) any
other Person for which a Person described in clause (ii) acts in any such capacity.
|
|
“Assets”of
a Person shall mean all of the assets, properties, businesses and rights of such Person
and its Subsidiaries of every kind, nature, character and description, whether real,
personal or mixed, tangible or intangible, accrued or contingent, including without
limitation any assets relating to or utilized in such Person’s business, directly or
indirectly, in whole or in part, whether or not carried on the books and records of such
Person, and whether or not owned in the name of such Person or any Affiliate of such
Person and wherever located.
|
|
“Code”or
“Internal Revenue Code” shall mean the Internal Revenue Code of 1986, as
amended, and the rules and regulations promulgated thereunder.
|
|
“Consent”shall
mean any consent, approval, authorization, clearance, exemption, waiver, or similar
affirmation by any Person pursuant to any Contract, Law, Order, or Permit.
|
|
“Contract”shall
mean any written or oral agreement, arrangement, authorization, commitment, contract,
indenture, instrument, lease, obligation, plan, practice, restriction, understanding or
undertaking of any kind or character, or other document to which any Person is a party or
that is binding on any Person or its capital stock, Assets or business.
|
|
“Default”shall
mean (i) any breach or violation of or default under any Contract, Order or Permit,
(ii) any occurrence of any event that with the passage of time or the giving of
notice or both would constitute a breach or violation of or default under any Contract,
Order or Permit, or (iii) any occurrence of any event that with or without the
passage of time or the giving of notice would give rise to a right to terminate or
revoke, change the current terms of, or renegotiate, or to accelerate, increase, or
impose any Liability under, any Contract, Order or Permit.
|
|
“ERISA”shall
mean the Employee Retirement Income Security Act of 1974, as amended.
|
|
“Environmental
Laws” shall mean all Laws relating to pollution or protection of human health or the
environment (including ambient air, surface water, ground water, land surface or
subsurface strata), including the Comprehensive Environmental Response Compensation and
Liability Act, as amended, 42 U.S.C. 9601 et seq. (“CERCLA”), the
Resource Conservation and Recovery Act, as amended, 42 U.S.C. 6901 et seq. (“RCRA”),
and other Laws relating to emissions, discharges, releases or threatened releases of any
Hazardous Substance, or otherwise relating to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of any Hazardous Substance.
|
|
“Exhibits”shall
mean the Exhibits so marked, copies of which are attached to this Agreement. Such
Exhibits are hereby incorporated by reference herein and made a part hereof, and may be
referred to in this Agreement and any other related instrument or document without being
attached hereto.
|
|
“GAAP”shall
mean generally accepted accounting principles, consistently applied during the periods
involved.
|
|
“Health
Care Laws” shall mean any state or federal law impacting the Business, including
without limitation, the federal Xxxx-Xxxxxxxx Xxxxxxx, 00 X.X.X. §0000x-0x, the
Civil Money Penalty Law, 42 U.S.C. §1320a-7a, the Ethics in Patient Referral Act, 42
U.S.C. §1399nn, the civil False Claims Act, 31 U.S.C. §§3729-3733,
Wisconsin Statutes §49.49 (Medical Assistance Offenses), Wisconsin Statutes §448.08
(Fee Splitting, etc.), and coverage laws, rules and determinations issued by the Centers
for Medicare & Medicaid Services (“CMS”) and/or CMS’s contractors.
|
-26-
|
“Information
Technology” means telecommunications equipment, computer equipment, software
programs, hardware and software documentation, databases, and other technology, including
all ownership, leasehold, and licensed rights to same.
|
|
“Intellectual
Property” shall mean the copyrights, patents, trademarks, service marks, service
names, tradenames, applications therefor, technology rights and licenses, computer
software (including, without limitation, any source or object codes therefor or
documentation relating thereto), trade secrets, franchises, know-how, inventions and
other intellectual property rights of a Person.
|
|
“IRS”shall
mean the United States Internal Revenue Service.
|
|
“Law” shall
mean any code, law (including common law), ordinance, regulation, reporting or licensing
requirement, rule, or statute applicable to a Person or its Assets, capital stock or
other securities, Liabilities or business, including those promulgated, interpreted or
enforced by any Regulatory Authority.
|
|
“Liability”shall
mean any direct or indirect, primary or secondary, liability, indebtedness, obligation,
penalty, cost or expense (including costs of investigation, collection and defense),
claim, deficiency, guaranty or endorsement of or by any Person (other than endorsements
of notes, bills, checks, and drafts presented for collection or deposit in the ordinary
course of business) of any type, whether accrued, absolute or contingent, liquidated or
unliquidated, matured or unmatured, or otherwise.
|
|
“Lien”shall
mean any conditional sale agreement, default of title, easement, encroachment,
encumbrance, hypothecation, infringement, lien, mortgage, pledge, reservation,
restriction, security interest, title retention or other security arrangement, or any
adverse right or interest, charge, or claim of any nature whatsoever of, on, or with
respect to any Asset, other than Liens for current property Taxes not yet due and
payable.
|
|
“Litigation”shall
mean any action, suit, arbitration, cause of action, claim, complaint, criminal
prosecution, demand letter, governmental or other examination or investigation, hearing,
inquiry, administrative or other proceeding, or notice (written or oral) by any Person
alleging potential Liability or requesting information relating to or affecting a party,
its business, its Assets (including Contracts related to it), or the transactions
contemplated by this Agreement.
|
|
“Material
Adverse Effect” shall mean an event, change or circumstance that, individually or
together with any other event, change or circumstance, has or could reasonably be
expected to have a material adverse impact on (i) the business, operations, Assets,
Liabilities, financial condition, prospects or results of operations of Seller, or (ii) the
ability of Seller or Shareholder to perform their respective obligations under this
Agreement or to consummate the transactions contemplated by this Agreement; provided that
a Material Adverse Effect shall not include any event, change or circumstance resulting
from changes in the economy in general which do not have a disproportionate effect on the
Target or its business, operations, Assets, Liabilities, financial condition, prospects
or results of operations.
|
|
“Order”shall
mean any administrative decision or award, decree, injunction, judgment, order,
quasi-judicial decision or award, ruling, or writ of any federal, state, local or foreign
or other court, arbitrator, mediator, tribunal, administrative agency or Regulatory
Authority.
|
|
“Oxygen-Related
Services” shall mean the provision of oxygen and any services, equipment and
supplies necessary to support the delivery of oxygen as supplied by Seller prior to the
Closing.
|
|
“Permit”shall
mean any federal, state, local, and foreign governmental approval, authorization,
certificate, easement, filing, franchise, license, notice, permit, or right to which any
Person is a party or that is or may be binding upon or inure to the benefit of any Person
or its securities or other ownership interests, Assets or business.
|
|
“Person”shall
mean a natural person or any legal, commercial or governmental entity, such as, but not
limited to, a corporation, general partnership, joint venture, limited partnership,
limited liability company, trust, business association, group acting in concert, or any
person acting in a representative capacity.
|
|
“Regulatory
Authorities” shall mean, collectively, all federal, state and local regulatory
agencies, authorities or other entities having jurisdiction over any party hereto or any
of its Subsidiaries.
|
|
“Representative”shall
mean any investment banker, financial advisor, attorney, accountant, consultant, or other
representative of a Person.
|
-27-
|
“Schedules”shall
mean the Schedules so marked, copies of which are attached to this Agreement. Such
Schedules are hereby incorporated by reference herein and made a part hereof, and may be
referred to in this Agreement and any other related instrument or document without being
attached hereto.
|
|
“Subsidiaries”shall
mean all those corporations, partnerships, associations, or other entities of which the
entity in question owns or controls 50% or more of the outstanding equity securities
either directly or through an unbroken chain of entities as to each of which 50% or more
of the outstanding equity securities is owned directly or indirectly by its parent;
provided, there shall not be included any such entity acquired through foreclosure or any
such entity the equity securities of which are owned or controlled in a fiduciary
capacity.
|
|
“Tax”or
“Taxes” shall mean any federal, state, county, local, or foreign taxes,
charges, fees, levies, imposts, duties, or other assessments, including income, gross
receipts, excise, employment, sales, use, transfer, license, payroll, franchise,
severance, stamp, occupation, windfall profits, environmental, federal highway use,
commercial rent, customs duties, capital stock, paid-up capital, profits, withholding,
Social Security, single business and unemployment, disability, real property, personal
property, registration, ad valorem, value added, alternative or add-on minimum,
estimated, or other tax or governmental fee of any kind whatsoever, imposed or required
to be withheld by the United States or any state, county, local or foreign government or
subdivision or agency thereof, including any interest, penalties, and additions imposed
thereon or with respect thereto, and including any transferee or secondary liability in
respect of any tax (whether imposed by law, contractual agreement or otherwise) and any
liability in respect of any tax as a result of being a member of any affiliated,
consolidated, combined, unitary or similar group.
|
|
“Tax
Return” means any return, declaration, report, statement and other document required
to be filed in respect of Taxes, and any claims for refunds of Taxes, including and any
amendments or supplements to any of the foregoing.
|
|
“Undisclosed
Liabilities” shall mean any Liability of Seller as of the indicated date, that is
not fully reflected or reserved against in August 31, 2004 balance sheet in the Financial
Statements.
|
|
(b) In
addition to the terms defined in Section 7.1(a) above, the terms set forth
below shall have the meanings ascribed thereto in the referenced sections:
|
|
|
401(k) Retirement Plan - Section 4.8
Acquisition - Section 1.1
Active Buying Customer - Section 1.4(a)
Additional Hired Employee - Section 4.8(a)
Allocable Consideration - Section 1.9
Allocation Schedule - Section 1.9
Assumed Contracts - Section 1.1(e)
Assumed Liabilities - Section 1.6
Benefit Plans - Section 2.21
Business - Preamble
Buyer Indemnified Party - Section 6.1(a)
Buyer Losses - Section 6.1(b)
Buyer Working Capital Statement - Section 1.5(c)
Certifications - Section 2.23
Closing - Section 1.2
Closing Date - Section 1.2
Closing Date Hired Employee - Section 4.8(a)
Closing Date Offered Employee - Section 4.8(a)
Disputed Loss - Section 6.6
Effective Hire Date - Section 4.8(a)
Employees - Section 2.18
Environmental Litigation - Section 2.15(a)
ERISA Affiliate - Section 2.21
ERISA Plan - Section 2.21
FASB 5 - Section 2.16
|
HIPAA - Section 2.26
Hired Employees - Section 4.8(a)
Indemnifiable Loss - Section 6.1(c)
Indemnitee - Section 6.1(d)
Indemnitor - Section 6.1(e)
Interim Financial Statements - Section 2.4(a)
Interim Period - Section 4.10
Large Customers - Section 2.22
Large Suppliers - Section 2.22
Leasing Fee - Section 4.8(i)
Lease Term - Section 4.8(c)
Loss - Section 6.1(f)
Measurement Period - Section 1.4(a)
Oxygen Employees - Section 4.10
Payors - Section 2.23
Prohibited Business - Section 4.7
Purchased Assets - Section 1.1
Purchased Inventory - Section 1.1(b)
Purchase Price - Section 1.3
Remuneration - Section 2.25
Retained Assets - Section 1.8
Retained Liabilities - Section 1.7
Revenue Statement - Section 1.4(b)
Revised Allocation Schedule - Section 1.9
Seller Indemnified Party - Section 6.1(g)
|
-28-
|
|
401(k) Retirement Plan - Section 4.8
Working Capital at Closing - Section 1.5(e)
Financial Statements - Section 2.4(a)
Gross Revenues of Existing Customers - Section 1.4(a)
Gross Revenues of New Customers - Section 1.4(a)
Health Policy - Section 4.8(g)
|
HIPAA - Section 2.26
Seller Losses - Section 6.1(h)
Seller's COBRA and HIPAA Obligations - Section
4.8(g)
Services - Section 4.8(b)
Total Revenue - Section 1.4(a)
WARN - Section 4.8(d)
Working Capital at Closing - Section 1.5(a)
Year-End Financial Statements - Section 2.4(a)
|
|
(c) Any
singular term in this Agreement shall be deemed to include the plural, and any
plural term the singular. Whenever the words “include,” “includes” or
“including” are used in this Agreement, they shall be deemed followed
by the words “without limitation.” |
7.2 |
Expenses.
Each of the parties hereto shall bear and pay all costs and expenses incurred by it
or on its behalf in connection with the transactions contemplated hereunder. |
7.3 |
Entire
Agreement. Except as otherwise expressly provided herein, this Agreement (including
the documents and instruments referred to herein) constitutes the entire agreement
between the parties hereto with respect to the transactions contemplated hereunder and
supersedes all prior arrangements or understandings with respect thereto, written or
oral. Nothing in this Agreement, expressed or implied, is intended to confer upon any
Person, other than the parties hereto or their respective successors, any rights,
remedies, obligations, or liabilities under or by reason of this Agreement, other than as
provided in Section 7.6 of this Agreement. |
7.4 |
Amendments.
This Agreement may be amended only by a subsequent writing signed by each of the parties
hereto. |
|
(a) Prior
to or at the Closing, Buyer, acting through its Board of Directors, chief
executive officer or other authorized officer, shall have the right to waive
any Default in the performance of any term of this Agreement by Seller, to
waive or extend the time for the compliance or fulfillment by Seller of any and
all of its obligations under this Agreement, and to waive any or all of the
conditions precedent to the obligations of Buyer under this Agreement, except
any condition which, if not satisfied, would result in the violation of any
Law. No such waiver shall be effective unless in writing signed by a duly
authorized officer of Buyer. |
|
(b) Prior
to or at the Closing, Seller, acting through its Shareholder or manager(s),
shall have the right to waive any Default in the performance of any term of
this Agreement by Buyer, to waive or extend the time for the compliance or
fulfillment by Buyer of any and all of their obligations under this Agreement,
and to waive any or all of the conditions precedent to the obligations of
Seller under this Agreement, except any condition which, if not satisfied,
would result in the violation of any Law. No such waiver shall be effective
unless in writing signed by a duly authorized officer of Seller. |
|
(c) The
failure of any party hereto at any time or times to require performance of any
provision hereof shall in no manner affect the right of such party at a later
time to enforce the same or any other provision of this Agreement. No waiver of
any condition or of the breach of any term contained in this Agreement in one
or more instances shall be deemed to be or construed as a further or continuing
waiver of such condition or breach or a waiver of any other condition or of the
breach of any other term of this Agreement. |
7.6 |
Assignment.
Except as expressly contemplated hereby, neither this Agreement nor any of the rights,
interests or obligations hereunder may be assigned by any party hereto (whether by
operation of Law or otherwise) without the prior written consent of the other parties;
provided that Buyer may assign its rights hereunder to PPS and/or may assign its rights
hereunder to secure its or PSS’ obligations under its or PSS’ lending
arrangements, in either or both cases without the consent of any other party hereto.
Subject to the preceding sentence, this Agreement will be binding upon, inure to the
benefit of and be enforceable by the parties hereto and their respective successors and
assigns. |
-29-
7.7 |
Notices.
All notices or other communications which are required or permitted hereunder shall be in
writing and sufficient if delivered by hand, by facsimile transmission, by registered or
certified mail, postage pre-paid, or by courier or overnight carrier, to the persons at
the addresses set forth below (or at such other address as may be provided hereunder),
and shall be deemed to have been delivered as of the date so delivered: |
|
|
Seller or Shareholder:
Copy to Counsel:
Buyer:
Copy to Counsel:
|
Xxxxxxxxx Corporation
00000 Xxxxxx Xxxx Xxxxx
Xxxxxxxxxxxx, Xxxxxxx 00000
Attention: Xxxxxxx X. Xxxxxxxxx
Facsimile: (000) 000-0000
Xxxxxxx XxXxxx LLP
0000 Xxxxxx Xxxxx
00 Xxxx Xxxxxx Xxxxxx
Xxxxxxxxxxxx, Xxxxxxx 00000
Attention: Xxxxxx X. Xxxxxx, Esq.
Facsimile: (000) 000-0000
Gulf South Medical Supply, Inc.
0000 Xxxxxxxxxx Xxxxxxxxx
Xxxxxxxxxxxx, Xxxxxxx 00000
Attention: Xxxxx Xxxxxxx
Facsimile: (000) 000-0000
Xxxxxx & Bird, LLP
0000 Xxxx Xxxxxxxxx Xxxxxx
Xxxxxxx, Xxxxxxx 00000-0000
Attention: Xxxx Xxxxxx, Esq.
Facsimile: (000) 000-0000
|
7.8 |
Governing
Law. This Agreement shall be governed by and construed in accordance with the
Laws of the State of Florida. |
7.9 |
Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed
to be an original, but all of which together shall constitute one and the same
instrument. |
7.10 |
Captions.
The captions contained in this Agreement are for reference purposes only and are not part
of this Agreement. |
7.11 |
Enforcement
of Agreement. The parties hereto agree that irreparable damage would occur in the
event that any of the provisions of this Agreement was not performed in accordance with
its specific terms or was otherwise breached. It is accordingly agreed that the parties
hereto shall be entitled to an injunction or injunctions to prevent breaches of this
Agreement and to enforce specifically the terms and provisions hereof in any court of the
United States or any state having jurisdiction, this being in addition to any other
remedy to which they are entitled at law or in equity. |
7.12 |
Severability.
Any term or provision of this Agreement which is invalid or unenforceable in any
jurisdiction shall, as to that jurisdiction, be ineffective to the extent of such
invalidity or unenforceability without rendering invalid or unenforceable the remaining
terms and provisions of this Agreement or affecting the validity or enforceability of any
of the terms or provisions of this Agreement in any other jurisdiction. If any provision
of this Agreement is so broad as to be unenforceable, the provision shall be interpreted
to be only so broad as is enforceable. |
7.13 |
Further
Assurances. Each party hereto covenants that at any time, and from time to time,
after the Closing Date, without additional consideration, it will execute such additional
instruments and take such actions as may be reasonably requested by the other parties to
confirm or perfect or otherwise to carry out the intent and purposes of this Agreement. |
-30-
IN
WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed on
its behalf on the day and year first above written.
|
|
|
GULF SOUTH MEDICAL SUPPLY, INC.
By:
Title:
PSS WORLD MEDICAL, INC.
By:
Title:
XXXXXXXXX CORPORATION
By:
Title:
SHAREHOLDER
Xxxxxxx X. Xxxxxxxxx
|